JPH07506561A - ポリマー合成に対する組合わせの戦略 - Google Patents
ポリマー合成に対する組合わせの戦略Info
- Publication number
- JPH07506561A JPH07506561A JP5509567A JP50956793A JPH07506561A JP H07506561 A JPH07506561 A JP H07506561A JP 5509567 A JP5509567 A JP 5509567A JP 50956793 A JP50956793 A JP 50956793A JP H07506561 A JPH07506561 A JP H07506561A
- Authority
- JP
- Japan
- Prior art keywords
- substrate
- reaction
- channel
- group
- channels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 98
- 230000015572 biosynthetic process Effects 0.000 title description 26
- 238000003786 synthesis reaction Methods 0.000 title description 24
- 238000000034 method Methods 0.000 claims abstract description 151
- 239000000758 substrate Substances 0.000 claims description 256
- 238000006243 chemical reaction Methods 0.000 claims description 141
- 239000000178 monomer Substances 0.000 claims description 131
- 239000000243 solution Substances 0.000 claims description 63
- 230000008878 coupling Effects 0.000 claims description 48
- 238000010168 coupling process Methods 0.000 claims description 48
- 238000005859 coupling reaction Methods 0.000 claims description 48
- 239000003153 chemical reaction reagent Substances 0.000 claims description 46
- 239000000376 reactant Substances 0.000 claims description 32
- 150000001413 amino acids Chemical class 0.000 claims description 31
- 238000003491 array Methods 0.000 claims description 31
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 28
- 125000006239 protecting group Chemical group 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 25
- 239000012530 fluid Substances 0.000 claims description 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 16
- 230000027455 binding Effects 0.000 claims description 15
- 230000002209 hydrophobic effect Effects 0.000 claims description 15
- 238000012546 transfer Methods 0.000 claims description 13
- 108091034117 Oligonucleotide Proteins 0.000 claims description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 10
- 238000000151 deposition Methods 0.000 claims description 9
- 230000002194 synthesizing effect Effects 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 8
- 238000009736 wetting Methods 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 5
- 238000001962 electrophoresis Methods 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 230000001568 sexual effect Effects 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 abstract description 11
- 108020003175 receptors Proteins 0.000 description 26
- 102000005962 receptors Human genes 0.000 description 26
- 235000001014 amino acid Nutrition 0.000 description 25
- 239000011159 matrix material Substances 0.000 description 19
- 230000008569 process Effects 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000003446 ligand Substances 0.000 description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 10
- -1 cofactors Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000010703 silicon Substances 0.000 description 8
- 229910052710 silicon Inorganic materials 0.000 description 8
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 125000005647 linker group Chemical group 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- 235000012431 wafers Nutrition 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 238000005530 etching Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 239000006163 transport media Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 102000006240 membrane receptors Human genes 0.000 description 2
- 108020004084 membrane receptors Proteins 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920002120 photoresistant polymer Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000005297 pyrex Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SWZCTMTWRHEBIN-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(O)C=C1 SWZCTMTWRHEBIN-QFIPXVFZSA-N 0.000 description 1
- RQJMOCIAILRHIC-JUUVMNCLSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound CC(C)C[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 RQJMOCIAILRHIC-JUUVMNCLSA-N 0.000 description 1
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229920005565 cyclic polymer Polymers 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000013023 gasketing Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036540 impulse transmission Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920000412 polyarylene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000001955 polymer synthesis method Methods 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- DGMKFQYCZXERLX-UHFFFAOYSA-N proglumide Chemical compound CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1 DGMKFQYCZXERLX-UHFFFAOYSA-N 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000012812 sealant material Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
- G01N35/1065—Multiple transfer devices
- G01N35/1072—Multiple transfer devices with provision for selective pipetting of individual channels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00364—Pipettes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00364—Pipettes
- B01J2219/00367—Pipettes capillary
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00364—Pipettes
- B01J2219/00367—Pipettes capillary
- B01J2219/00369—Pipettes capillary in multiple or parallel arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00378—Piezoelectric or ink jet dispensers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00389—Feeding through valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00414—Means for dispensing and evacuation of reagents using suction
- B01J2219/00416—Vacuum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/0043—Means for dispensing and evacuation of reagents using masks for direct application of reagents, e.g. through openings in a shutter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/00432—Photolithographic masks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00457—Dispensing or evacuation of the solid phase support
- B01J2219/00475—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/005—Beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00529—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00531—Sheets essentially square
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00536—Sheets in the shape of disks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00617—Delimitation of the attachment areas by chemical means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00675—In-situ synthesis on the substrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00711—Light-directed synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Composite Materials (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polymerisation Methods In General (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Peptides Or Proteins (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Graft Or Block Polymers (AREA)
- Materials For Medical Uses (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Moulding By Coating Moulds (AREA)
Abstract
Description
Claims (47)
- 1.複数の選択された領域を有する表面からなる単一の基板上に、多様なモノマ ー配列を有するポリマーを形成する方法であって;下記ステップ;すなわち (a)前記表面に隣接して複数のチャネルを形成し、そのチャネルは少なくとも 部分的に、前記の選択された領域の部分によって形成された壁を有し; (b)選択されたモノマーを前記チャネルに入れ、前記の選択された領域の前記 部分においてポリマーを合成し、前記の選択された領域の前記部分は前記の選択 された領域中の少なくとも一つの他の領域内のポリマーと異なるモノマーの配列 を有するポリマーを含有し;次いで (c)前記の選択された領域の第二の部分にそって形成された前記チャネルにつ いてステップ(a)と(b)を繰返す;ステップからなる方法。
- 2.複数のチャネルを形成する前記ステップが、前記表面に隣接してチャネルブ ロックを配置するステップからなり、前記チャネルブロックが、複数の溝、前記 溝の壁および前記フローチャネルを少なくとも部分的に形成する前記表面を備え ている請求の範囲第1項記載の方法。
- 3.選択された試薬を前記チャネル中に入れるステップが、下記のステップ:す なわち 少なくとも第1チャネルの活性部位から保護基を除き;第一モノマーを、前記の 少なくとも第一チャネルを通じて、流入させ、前記第一モノマーが保護基を有し 、前記第一モノマーを前記第一チャネルの前記活性部位に結合させ;少なくとも 第二チャネルの前記活性化部位から保護基を除去し、前記第二チャネルの少なく とも部分が、前記第一チャネルが接触している前記基板の部分に重なり;次いで 第二モノマーを前記の少なくとも第二チャネルを通じて流入させ、前記第二モノ マーを前記第二チャネルの前記活性部位に結合させる;ステップからなる請求の 範囲第1項記載の方法。
- 4.前記ポリマーを、受容体との結合アフィニティーについてスクリーニングす るステップをさらに有する請求の範囲第1項記載の方法。
- 5.少なくとも10種の異なるポリマーを前記表面上に生成させる請求の範囲第 1項記載の方法。
- 6.少なくとも1,000種の異なるポリマーを前記表面上に生成させる請求の 範囲第1項記載の方法。
- 7.少なくとも10,000種の異なるポリマーを前記表面上に生成させる請求 の範囲第1項記載の方法。
- 8.前記ポリマーがオリゴヌクレオチドおよびペプチドからなる群から選択され る請求の範囲第1項記載の方法。
- 9.前記の選択された領域が各々約10,000ミクロン2未満の面積を有する 請求の範囲第1項記載の方法。
- 10.除去および流入のステップがさらに、チャネルブロックを、第一方向に、 前記表面と接触させて配置し、次いで第一モノマーを含有する物質を、前記チャ ネルブロックの少なくとも二つのチャネルを通じて入れ;前記チャネルブロック および前記基板のうちの一方を、残りの他方に対して回転し;次いで チャネルブロックを、第二方向に、前記表面と接触させて配置し、次いで第二モ ノマーを含有する物質を、前記チャネルブロックの少なくとも一つのチャネルを 通じて入れる;ステップを含んでいる請求の範囲第3項記載の方法。
- 11.選択された試薬を前記チャネルに入れる前記ステップが、前記チャネルと 流体で連通させてピペットを配置し;および前記選択された試薬を前記チャネル を通じて注入する;ことからなる請求の範囲第1項記載の方法。
- 12.ピペットを前記チャネルと流体で連通させて配置する前記ステップが、前 記ピペットを、前記基板の前記表面に対して反対側の面上のオリフィスと接触さ せて配置するステップである請求の範囲第11項記載の方法。
- 13.ピペットを前記チャネルと流体で連通させて配置する前記ステップが、複 数のピペットを、複数の前記チャネルと連通させて配置し、次いで異なる試薬を 少なくとも二つの前記チャネルを通じて流入させるステップである請求の範囲第 11項記載の方法。
- 14.前記表面のパルプのアレーを形成して流体が前記表面の所望の場所に導入 可能になり、次いで前記バルブを選択的に作動させ次に前記の選択された試薬を 形成されたチャネルを通じて流入させるステップが先行している請求の範囲第1 項記載の方法。
- 15.前記基板の部分に光を照射して、光排除性基が前記基板上の活性基から除 去されるステップが先行している請求の範囲第1項記載の方法。
- 16.前記の選択された光照射部分がストライプの形態であり、かつチャネルを 形成する前記ステップが前記チャネルを前記ストライプの経路にそって形成るこ とを含み、異なる試薬が前記チャネルの少なくとも一部の中に入れられる請求の 範囲第15項記載の方法。
- 17.単一の基板の表面上に複数のピペットの配列を形成する方法であって;下 記のステップすなわち a)前記基板を、第一方向に、複数のチャネルを有するチャネルブロックと接触 させて配列し; b)少なくとも第一アミノ酸を、少なくとも一つの前記チャネルを通じて流入さ せ、前記第一アミノ酸を前記表面の部分にカップリングさせ; c)少なくとも第二アミノ酸を、少なくとも一つの前記チャネルを通じて流入さ せ、前記第二アミノ酸を前記表面の部分にカップリングさせ; d)前記チャネルブロックを前記基板に対して回転させ、次いで前記基板を再び 前記チャネルブロックと接触させて配置し;e)第三アミノ酸を少なくとも一つ の前記チャネルを通じて流入させて前記表面上に少なくとも第一と第二のペプチ ド配列を形成し;次いで f)第四アミノ酸を少なくとも一つの前記チャネルを通じて流入させて前記表面 上に少なくとも第三と第四のペプチド配列を形成する; ステップからなる方法。
- 18.基板; 複数の溝を備えたチャネルブロック; 前記チャネルブロックを前記基板と係合させて保持する手段;前記チャネルブロ ックおよび前記基板のうちの一方を、残りの他方に対して平行移動させる手段; および選択された試薬を前記溝に注入する手段;からなる多様なポリマー配列を 形成するのに用いるキット。
- 19.前記基板が活性部位の保護基を有する請求の範囲第18項記載のキット。
- 20.さらに、前記保護基を除去するのに用いる脱保護物質を有する請求の範囲 第19項記載のキット。
- 21.前記溝が前記チャネルブロックの孔に接続され、前記孔が前記基板の背面 を通って延びている請求の範囲第18項記載のキット。
- 22.さらに、前記基板の選択された部分に光を照射して前記基板上の保護基を 除去する手段を有し、前記保護基は光に暴露されると前記基板上の活性部位から 除去される請求の範囲第18項記載のキット。
- 23.光を照射する前記手段が光源と光マスクを有し、前記光マスクが前記光を 透過しない領域および前記光を透過する領域を有する請求の範囲第22項記載の キット。
- 24.前記注入手段がピペッタからなる請求の範囲第18項記載のキット。
- 25.前記ピペッタが複数のピペットからなり、各ピペットが前記溝の異なる一 つに取付けられている請求の範囲第24項記載のキット。
- 26.単一の基板上で複数の反応を行う装置であって;単一の基板上に存在し、 各々別個の反応を行うことができる少なくとも約100個の反応領域; 一つ以上の反応物を一つ以上の反応領域に送り込む手段;および少なくともいく つかの反応物が少なくともいくつかの反応領域と接触するのを防止する手段; を有する装置。
- 27.基板が複数の流路を有し、反応が前記流路内に保持されている請求の範囲 第26項記載の装置。
- 28.一つ以上の反応物を送り込む手段が基板に隣接しているチャネルブロック のフローチャネルであり、および少なくともいくつかの反応物を閉じこめている 手段がフローチャネルの壁である請求の範囲第26項記載の装置。
- 29.少なくともいくつかの反応物を閉じこめている手段が基板の表面上の疎水 性層である請求の範囲第26項記載の装置。
- 30.内部に異なる化合物を有する約100個より多い反応領域;および 反応領域を囲みかつ疎水性が反応領域より高い閉じこめ領域;を有する基板。
- 31.閉じこめ領域が疎水性保護基を有する請求の範囲第30項記載の基板。
- 32.保護基が光分解性である請求の範囲第31項記載の基板。
- 33.反応領域がチャネルを形成する請求の範囲第30項記載の基板。
- 34.基板が約1000個より多い反応領域を有する請求の範囲第30項記載の 基板。
- 35.閉じこめ領域に囲まれ、この領域より一つ以上のモノマー溶液によって漏 れ易い複数の反応領域を有する基板上に、多様なモノマー配列を有する複数のポ リマーを形成する方法であって;一つ以上のモノマー溶液を順に第一反応領域に 入れて第一モノマー配列を有する第一ポリマーを形成し、そのモノマー溶液は閉 じこめ領域によって第一反応領域に閉じこめられ;次いで一つ以上のモノマー溶 液を順に第二反応領域に入れて第二モノマー配列を有する第二ポリマーを形成し 、そのモノマー溶液は閉じこめ領域によって第一反応領域に閉じこめられている ;ことからなる方法。
- 36.モノマー溶液を第一反応領域に入れるステップが、ピペットを基板に対し て移動し次いで少なくとも一つのモノマー溶液を第一反応領域に堆積させること からなる請求の範囲第35項記載の方法。
- 37.さらに、選択されたモノマーを第一ポリマーと第二ポリマーにカップリン グさせた後、モノマー溶液を、第一反応領域と第二反応領域から定期的に除去す るステップを有する請求の範囲第35項記載の方法。
- 38.第一モノマーを第一反応領域にカップリングさせ次いで第二モノマーを第 二反応領域にカップリングさせ、その後追加のモノマーを、第一反応領域および 第二反応領域に入れてカップリングさせる請求の範囲第35項記載の方法。
- 39.モノマー溶液を、電気泳動ポンプ、ピペットおよび荷電波滴ディスペンサ ーからなる群から選択されるディスペンサーによって第一反応領域と第二反応領 域に入れる請求の範囲第35項記載の方法。
- 40.単一基板上の、複数の反応領域を有する化合物の非相同アレーを変換する 方法であって;下記のステップすなわち第一群の反応領域と第二群の反応領域を 活性化し;第一反応物を第一群の反応領域に送りこむが第二群の反応領域には送 りこまず; 第一反応物を第一群の反応領域で反応させて第一非相同アレーを第二非相同アレ ーに変換し、その非相同アレーが約100個を越える別個の反応領域を有する; ステップからなる方法。
- 41.さらに、第一群の反応領域を第二群の反応領域から隔離するステップを有 する請求の範囲第40項記載の方法。
- 42.第一群の反応領域を、チャネルブロックを基板に当接させて配置すること によって隔離する請求の範囲第41項記載の方法。
- 43.第一群の反応領域を、基板上の壁によって第二群の反応領域から隔離する 請求の範囲第40項記載の方法。
- 44.基板が、壁によって互いに隔離された反応領域を通過する一連の流れを有 する請求の範囲第43項記載の方法。
- 45.第一群の反応領域を、基板上の一つ以上の非湿潤領域によって第二群の反 応領域から隔離する請求の範囲第40項記載の方法。
- 46.非相同アレーが約1000個を越える別個の反応領域を有する請求の範囲 第40項記載の方法。
- 47.さらに、下記のステップ:すなわち第二反応物を第二群の反応領域に送り こむが第一群の反応領域には送りこまず; 第二反応物を第二群の反応領域で反応させ;第三群の反応領域を活性化させ、そ の第三群は第一群の反応領域と共通のいくつかの反応領域を有し; 反応物を第三群の反応領域に送りこむが第二群の反応領域には送りこまず;そし て 反応を第三群の反応領域で起こさせる;ステップを有する、請求の範囲第40項 記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/796,243 US5384261A (en) | 1991-11-22 | 1991-11-22 | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US796.243 | 1991-11-22 | ||
US07/874,849 US5412087A (en) | 1992-04-24 | 1992-04-24 | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
US874.849 | 1992-04-24 | ||
PCT/US1992/010183 WO1993009668A1 (en) | 1991-11-22 | 1992-11-20 | Combinatorial strategies for polymer synthesis |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002136772A Division JP2003061657A (ja) | 1991-11-22 | 2002-05-13 | ポリマー合成に対する組合わせの戦略 |
JP2006032668A Division JP2006194897A (ja) | 1991-11-22 | 2006-02-09 | ポリマー合成に対する組合わせの戦略 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07506561A true JPH07506561A (ja) | 1995-07-20 |
JP3939338B2 JP3939338B2 (ja) | 2007-07-04 |
Family
ID=27121714
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50956793A Expired - Lifetime JP3939338B2 (ja) | 1991-11-22 | 1992-11-20 | ポリマー合成に対する組合わせの戦略 |
JP2002136772A Pending JP2003061657A (ja) | 1991-11-22 | 2002-05-13 | ポリマー合成に対する組合わせの戦略 |
JP2006032668A Pending JP2006194897A (ja) | 1991-11-22 | 2006-02-09 | ポリマー合成に対する組合わせの戦略 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002136772A Pending JP2003061657A (ja) | 1991-11-22 | 2002-05-13 | ポリマー合成に対する組合わせの戦略 |
JP2006032668A Pending JP2006194897A (ja) | 1991-11-22 | 2006-02-09 | ポリマー合成に対する組合わせの戦略 |
Country Status (9)
Country | Link |
---|---|
US (3) | US5677195A (ja) |
EP (5) | EP0972564B1 (ja) |
JP (3) | JP3939338B2 (ja) |
AT (3) | ATE293011T1 (ja) |
AU (1) | AU675054B2 (ja) |
CA (1) | CA2124087C (ja) |
DE (3) | DE69233331T3 (ja) |
HK (1) | HK1025278A1 (ja) |
WO (1) | WO1993009668A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011754A1 (fr) * | 1997-08-29 | 1999-03-11 | Olympus Optical Co., Ltd. | Capillaire d'adn |
JP2000514844A (ja) * | 1996-01-23 | 2000-11-07 | ノバルティス アクチエンゲゼルシャフト | 高分子を合成する装置および方法 |
JP2002525590A (ja) * | 1998-08-28 | 2002-08-13 | フェビット フェラリウス バイオテクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング | 分析物測定法のための支持体および該支持体を製造する方法 |
JP2002357607A (ja) * | 2002-03-20 | 2002-12-13 | Olympus Optical Co Ltd | 集積化反応装置 |
JP2003509577A (ja) * | 1999-09-20 | 2003-03-11 | ゼネラル・エレクトリック・カンパニイ | パラレル重合法 |
US6559296B2 (en) | 1997-08-29 | 2003-05-06 | Olympus Optical Co., Ltd. | DNA capillary |
JP2004532382A (ja) * | 2000-09-27 | 2004-10-21 | サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シアンティフィク−シーエヌアールエス | 複数の異なるポリヌクレオチドおよび/またはペプチド配列を保有する支持体を製造するための方法および装置 |
US7359030B2 (en) | 2002-11-29 | 2008-04-15 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
JP2011154043A (ja) * | 1996-02-09 | 2011-08-11 | Cornell Research Foundation Inc | アドレス可能アレイでのリガーゼ検出反応を用いた核酸配列の相違の検出 |
Families Citing this family (899)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054270A (en) * | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US6919211B1 (en) * | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
EP0562047A4 (en) * | 1990-12-06 | 1995-11-02 | Affymax Tech Nv | Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides |
US6943034B1 (en) * | 1991-11-22 | 2005-09-13 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
EP0972564B1 (en) † | 1991-11-22 | 2003-05-28 | Affymetrix, Inc. (a Delaware Corporation) | Method of forming arrays of polymers |
US5573905A (en) * | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
US6767510B1 (en) | 1992-05-21 | 2004-07-27 | Biosite, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US7524456B1 (en) * | 1992-05-21 | 2009-04-28 | Biosite Incorporated | Diagnostic devices for the controlled movement of reagents without membranes |
US6905882B2 (en) * | 1992-05-21 | 2005-06-14 | Biosite, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
WO1994002515A1 (en) * | 1992-07-21 | 1994-02-03 | Bunsen Rush Laboratories Inc. | Oligomer library formats and methods relating thereto |
US5420328A (en) * | 1992-09-11 | 1995-05-30 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
WO1994008051A1 (en) * | 1992-10-01 | 1994-04-14 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
US6436635B1 (en) | 1992-11-06 | 2002-08-20 | Boston University | Solid phase sequencing of double-stranded nucleic acids |
US5807683A (en) * | 1992-11-19 | 1998-09-15 | Combichem, Inc. | Combinatorial libraries and methods for their use |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
IL106106A0 (en) * | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
US6401267B1 (en) * | 1993-09-27 | 2002-06-11 | Radoje Drmanac | Methods and compositions for efficient nucleic acid sequencing |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US7375198B2 (en) | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US20030232361A1 (en) * | 1993-10-26 | 2003-12-18 | Affymetrix, Inc. | Nucleic acid array preparation using purified phosphoramidites |
US5429807A (en) * | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
US6893816B1 (en) * | 1993-10-28 | 2005-05-17 | Houston Advanced Research Center | Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
US6254827B1 (en) | 1993-11-01 | 2001-07-03 | Nanogen, Inc. | Methods for fabricating multi-component devices for molecular biological analysis and diagnostics |
US6225059B1 (en) | 1993-11-01 | 2001-05-01 | Nanogen, Inc. | Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics |
US6315953B1 (en) | 1993-11-01 | 2001-11-13 | Nanogen, Inc. | Devices for molecular biological analysis and diagnostics including waveguides |
US6099803A (en) * | 1994-07-07 | 2000-08-08 | Nanogen, Inc. | Advanced active electronic devices for molecular biological analysis and diagnostics |
US6726880B1 (en) | 1993-11-01 | 2004-04-27 | Nanogen, Inc. | Electronic device for performing active biological operations and method of using same |
US6331274B1 (en) | 1993-11-01 | 2001-12-18 | Nanogen, Inc. | Advanced active circuits and devices for molecular biological analysis and diagnostics |
US6068818A (en) | 1993-11-01 | 2000-05-30 | Nanogen, Inc. | Multicomponent devices for molecular biological analysis and diagnostics |
JPH09507487A (ja) * | 1994-01-05 | 1997-07-29 | アーキュール,インコーポレーテッド | 選ばれた性質を有するアミンイミドおよびオキサゾロンをベースとした分子の系統的モジュール製造 |
WO1995019359A1 (en) * | 1994-01-12 | 1995-07-20 | Massachusetts Institute Of Technology | Process for making xanthene or cubane based compounds, and protease inhibitors |
GB9401833D0 (en) * | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
US6741344B1 (en) | 1994-02-10 | 2004-05-25 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
US6015880A (en) * | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
DE69527585T2 (de) * | 1994-06-08 | 2003-04-03 | Affymetrix Inc | Verfahren und Vorrichtung zum Verpacken von Chips |
US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
US7615368B1 (en) * | 1994-06-17 | 2009-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Microarrays of polypeptides |
US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US7378236B1 (en) | 1994-06-17 | 2008-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Method for analyzing gene expression patterns |
US7323298B1 (en) | 1994-06-17 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Microarray for determining the relative abundances of polynuceotide sequences |
US5939268A (en) * | 1994-07-26 | 1999-08-17 | The Scripps Research Institute | Combinatorial libraries of molecules and methods for producing same |
US6558633B1 (en) * | 1994-09-21 | 2003-05-06 | Isis Pharmaceuticals, Inc. | Chemical reaction apparatus and methods |
US6121048A (en) * | 1994-10-18 | 2000-09-19 | Zaffaroni; Alejandro C. | Method of conducting a plurality of reactions |
US6004617A (en) * | 1994-10-18 | 1999-12-21 | The Regents Of The University Of California | Combinatorial synthesis of novel materials |
US5985356A (en) * | 1994-10-18 | 1999-11-16 | The Regents Of The University Of California | Combinatorial synthesis of novel materials |
US7767627B1 (en) | 1994-10-18 | 2010-08-03 | Symyx Solutions, Inc. | Combinatorial synthesis of inorganic or composite materials |
US5603351A (en) * | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
US5959098A (en) * | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
US6239273B1 (en) | 1995-02-27 | 2001-05-29 | Affymetrix, Inc. | Printing molecular library arrays |
US5599695A (en) * | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
CZ299135B6 (cs) * | 1995-03-10 | 2008-04-30 | Meso Scale Technologies, Llc. Corporation Servicecompany | Kazeta a zarízení pro použití pri detekci analytu, zpusob provádení testu za použití uvedené kazety, kit pro použití pri provádení množiny elektrochemiluminescencních testu a zpusob detekce nebo merení analytu |
US6428955B1 (en) | 1995-03-17 | 2002-08-06 | Sequenom, Inc. | DNA diagnostics based on mass spectrometry |
AU4424496A (en) * | 1995-03-27 | 1996-10-16 | Warner-Lambert Company | A method for the synthesis of mixtures of compounds |
US5922534A (en) | 1995-03-28 | 1999-07-13 | Hewlett-Packard Company | Dry biochemical assay plate and method for making the same |
US7803529B1 (en) | 1995-04-11 | 2010-09-28 | Sequenom, Inc. | Solid phase sequencing of biopolymers |
US5830655A (en) | 1995-05-22 | 1998-11-03 | Sri International | Oligonucleotide sizing using cleavable primers |
US5776674A (en) * | 1995-06-05 | 1998-07-07 | Seq, Ltd | Chemical biochemical and biological processing in thin films |
US5767238A (en) * | 1995-06-07 | 1998-06-16 | Combichem, Inc. | Inverse solid phase synthesis |
US6720149B1 (en) * | 1995-06-07 | 2004-04-13 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
US20050100946A1 (en) * | 1995-06-29 | 2005-05-12 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device and method for in-situ confocal microscopy |
US6168948B1 (en) | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
DE69632989T2 (de) | 1995-10-17 | 2005-08-25 | Combichem, Inc., San Diego | Matrize für die Synthese kombinatorischer Bibliotheken in Lösung |
US6953663B1 (en) | 1995-11-29 | 2005-10-11 | Affymetrix, Inc. | Polymorphism detection |
US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
US5906606A (en) | 1995-12-04 | 1999-05-25 | Target Therapuetics, Inc. | Braided body balloon catheter |
US6022963A (en) * | 1995-12-15 | 2000-02-08 | Affymetrix, Inc. | Synthesis of oligonucleotide arrays using photocleavable protecting groups |
US20110028350A1 (en) * | 1995-12-15 | 2011-02-03 | Affymetrix, Inc. | Photocleavable protecting groups |
US6147205A (en) * | 1995-12-15 | 2000-11-14 | Affymetrix, Inc. | Photocleavable protecting groups and methods for their use |
US6852487B1 (en) | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
US6063633A (en) | 1996-02-28 | 2000-05-16 | The University Of Houston | Catalyst testing process and apparatus |
CA2248084A1 (en) | 1996-03-04 | 1997-09-12 | Genetrace Systems, Inc. | Methods of screening nucleic acids using mass spectrometry |
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
US6114122A (en) | 1996-03-26 | 2000-09-05 | Affymetrix, Inc. | Fluidics station with a mounting system and method of using |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
US6706875B1 (en) * | 1996-04-17 | 2004-03-16 | Affyemtrix, Inc. | Substrate preparation process |
NZ332116A (en) | 1996-05-03 | 2000-06-23 | Warner Lambert Co | Rapid purification of synthetic intermediates and products by polymer supported quench reagents |
US5981956A (en) | 1996-05-16 | 1999-11-09 | Affymetrix, Inc. | Systems and methods for detection of labeled materials |
US5958342A (en) * | 1996-05-17 | 1999-09-28 | Incyte Pharmaceuticals, Inc. | Jet droplet device |
SE9602545L (sv) * | 1996-06-25 | 1997-12-26 | Michael Mecklenburg | Metod för att diskriminera komplexa biologiska prover |
US5858666A (en) * | 1996-08-29 | 1999-01-12 | Biotechnology Research And Development Corporation | Apparatus and method of detection employing an AC frequency sensor array |
US5965363A (en) | 1996-09-19 | 1999-10-12 | Genetrace Systems Inc. | Methods of preparing nucleic acids for mass spectrometric analysis |
CA2702219C (en) * | 1996-11-06 | 2013-01-08 | Sequenom, Inc. | High density immobilization of nucleic acids |
CA2270132A1 (en) * | 1996-11-06 | 1998-05-14 | Sequenom, Inc. | Dna diagnostics based on mass spectrometry |
US6133436A (en) * | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
US6024925A (en) | 1997-01-23 | 2000-02-15 | Sequenom, Inc. | Systems and methods for preparing low volume analyte array elements |
US7285422B1 (en) | 1997-01-23 | 2007-10-23 | Sequenom, Inc. | Systems and methods for preparing and analyzing low volume analyte array elements |
DE19648695C2 (de) * | 1996-11-25 | 1999-07-22 | Abb Patent Gmbh | Vorrichtung zur automatischen und kontinuierlichen Analyse von Flüssigkeitsproben |
EP0963443B1 (en) * | 1996-12-10 | 2006-03-08 | Sequenom, Inc. | Releasable nonvolatile mass-label molecules |
US6083763A (en) * | 1996-12-31 | 2000-07-04 | Genometrix Inc. | Multiplexed molecular analysis apparatus and method |
DE19705910C1 (de) * | 1997-02-15 | 1998-06-18 | Inst Physikalische Hochtech Ev | Mikrokammerarray mit hoher Kammerdichte |
US20020015997A1 (en) * | 1997-06-16 | 2002-02-07 | Lafferty William Michael | Capillary array-based sample screening |
US6207370B1 (en) | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
US7252950B1 (en) | 1997-09-04 | 2007-08-07 | The Regents Of The University Of California | Assays for detecting modulators of cytoskeletal function |
CN1677076A (zh) * | 1997-09-11 | 2005-10-05 | 生物风险公司 | 制备高密度阵列的方法 |
US20020155495A1 (en) * | 2000-04-17 | 2002-10-24 | Millstein Larry S. | Method for producing arrays and devices relating thereto |
US6228659B1 (en) | 1997-10-31 | 2001-05-08 | PE Corporation (“NY”) | Method and apparatus for making arrays |
US6235871B1 (en) | 1997-12-03 | 2001-05-22 | Massachusetts Institute Of Technology | Synthesis of oligoarylamines, and uses and reagents related thereto |
US6268131B1 (en) | 1997-12-15 | 2001-07-31 | Sequenom, Inc. | Mass spectrometric methods for sequencing nucleic acids |
US6083682A (en) * | 1997-12-19 | 2000-07-04 | Glaxo Group Limited | System and method for solid-phase parallel synthesis of a combinatorial collection of compounds |
US20030096232A1 (en) * | 1997-12-19 | 2003-05-22 | Kris Richard M. | High throughput assay system |
US20030039967A1 (en) * | 1997-12-19 | 2003-02-27 | Kris Richard M. | High throughput assay system using mass spectrometry |
US20100105572A1 (en) * | 1997-12-19 | 2010-04-29 | Kris Richard M | High throughput assay system |
US6289229B1 (en) | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US7794946B1 (en) | 1998-02-04 | 2010-09-14 | Life Technologies Corporation | Microarray and uses therefor |
EP0947246B1 (en) * | 1998-02-04 | 2004-08-18 | Corning Incorporated | Substrate for array printing |
DE69909972T2 (de) * | 1998-02-11 | 2004-05-13 | University Of Houston, Houston | Vorrichtung zur durchführung chemischer und biochemischer reaktionen unter anwendung von photoerzeugten reagenzien |
US6117396A (en) * | 1998-02-18 | 2000-09-12 | Orchid Biocomputer, Inc. | Device for delivering defined volumes |
EP1054949A4 (en) * | 1998-02-20 | 2006-09-27 | Nanogen Inc | ACTIVE EVOLVED DEVICES AND METHODS OF ANALYSIS AND DIAGNOSIS IN MOLECULAR BIOLOGY |
US20030215957A1 (en) * | 1998-02-20 | 2003-11-20 | Tony Lemmo | Multi-channel dispensing system |
ATE464946T1 (de) * | 1998-02-23 | 2010-05-15 | Wisconsin Alumni Res Found | Verfahren und vorrichtung zur synthese von dan- sonderanordnungen |
US6407816B1 (en) * | 1998-02-23 | 2002-06-18 | Zygo Corporation | Interferometer and method for measuring the refractive index and optical path length effects of air |
US6087103A (en) * | 1998-03-04 | 2000-07-11 | Lifespan Biosciences, Inc. | Tagged ligand arrays for identifying target-ligand interactions |
EP1717249A1 (en) | 1998-03-12 | 2006-11-02 | Georgetown University | Peptides containing a cholesterol recognition sequence and their uses |
US6723564B2 (en) | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
US6872535B2 (en) | 1998-05-20 | 2005-03-29 | Aventis Pharmaceuticals Inc. | Three-dimensional array of supports for solid-phase parallel synthesis and method of use |
US6271957B1 (en) * | 1998-05-29 | 2001-08-07 | Affymetrix, Inc. | Methods involving direct write optical lithography |
US6858423B1 (en) | 1998-06-05 | 2005-02-22 | The Regents Of The University Of California | Optical Amplification of molecular interactions using liquid crystals |
US6284197B1 (en) * | 1998-06-05 | 2001-09-04 | The Regents Of The University Of California | Optical amplification of molecular interactions using liquid crystals |
US6780582B1 (en) * | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
US20030138973A1 (en) * | 1998-07-14 | 2003-07-24 | Peter Wagner | Microdevices for screening biomolecules |
US6682942B1 (en) | 1998-07-14 | 2004-01-27 | Zyomyx, Inc. | Microdevices for screening biomolecules |
US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
US20020119579A1 (en) * | 1998-07-14 | 2002-08-29 | Peter Wagner | Arrays devices and methods of use thereof |
US6897073B2 (en) * | 1998-07-14 | 2005-05-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
US6908770B1 (en) | 1998-07-16 | 2005-06-21 | Board Of Regents, The University Of Texas System | Fluid based analysis of multiple analytes by a sensor array |
US6830934B1 (en) * | 1999-06-15 | 2004-12-14 | Lifescan, Inc. | Microdroplet dispensing for a medical diagnostic device |
US6521182B1 (en) * | 1998-07-20 | 2003-02-18 | Lifescan, Inc. | Fluidic device for medical diagnostics |
US6461812B2 (en) | 1998-09-09 | 2002-10-08 | Agilent Technologies, Inc. | Method and multiple reservoir apparatus for fabrication of biomolecular arrays |
DE69917914T2 (de) * | 1998-09-18 | 2004-11-04 | Symyx Technologies, Inc., Santa Clara | Herstellung von kombinatorischen arrays von materialen durch methoden der synthese in lösung |
US6203989B1 (en) | 1998-09-30 | 2001-03-20 | Affymetrix, Inc. | Methods and compositions for amplifying detectable signals in specific binding assays |
US7071324B2 (en) | 1998-10-13 | 2006-07-04 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
US6262216B1 (en) * | 1998-10-13 | 2001-07-17 | Affymetrix, Inc. | Functionalized silicon compounds and methods for their synthesis and use |
US7034143B1 (en) | 1998-10-13 | 2006-04-25 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
CA2347125A1 (en) * | 1998-10-16 | 2000-04-27 | Larry S. Millstein | Methods of making patterned arrays of analyte-binding molecules |
WO2000040334A1 (en) | 1999-01-08 | 2000-07-13 | Pe Corporation (Ny) | Fiber array for contacting chemical species and methods for using and making same |
US20050026209A1 (en) * | 1999-01-08 | 2005-02-03 | Vann Charles S. | Optical fiber bundle for detecting binding of chemical species |
US7595189B2 (en) * | 1999-01-08 | 2009-09-29 | Applied Biosystems, Llc | Integrated optics fiber array |
US6291516B1 (en) | 1999-01-13 | 2001-09-18 | Curis, Inc. | Regulators of the hedgehog pathway, compositions and uses related thereto |
US6432719B1 (en) | 1999-02-16 | 2002-08-13 | Pe Corporation (Ny) | Matrix storage and dispensing system |
US7101510B2 (en) | 1999-02-16 | 2006-09-05 | Applera Corporation | Matrix storage and dispensing system |
AU762897B2 (en) * | 1999-02-16 | 2003-07-10 | Applera Corporation | Bead dispensing system |
AU767606B2 (en) * | 1999-02-19 | 2003-11-20 | Synthetic Genomics, Inc. | Method for producing polymers |
US6319476B1 (en) | 1999-03-02 | 2001-11-20 | Perseptive Biosystems, Inc. | Microfluidic connector |
US20030186226A1 (en) * | 1999-03-08 | 2003-10-02 | Brennan Thomas M. | Methods and compositions for economically synthesizing and assembling long DNA sequences |
US6296702B1 (en) | 1999-03-15 | 2001-10-02 | Pe Corporation (Ny) | Apparatus and method for spotting a substrate |
DE19913076A1 (de) | 1999-03-23 | 2000-10-19 | Hahn Schickard Ges | Vorrichtung und Verfahren zum Aufbringen von Mikrotröpfchen auf ein Substrat |
AU3431400A (en) * | 1999-03-24 | 2000-10-09 | Torsana Biosensor A/S | Spatially directed interaction on a solid surface |
US6582906B1 (en) | 1999-04-05 | 2003-06-24 | Affymetrix, Inc. | Proportional amplification of nucleic acids |
US6824866B1 (en) * | 1999-04-08 | 2004-11-30 | Affymetrix, Inc. | Porous silica substrates for polymer synthesis and assays |
WO2000066259A1 (en) * | 1999-05-05 | 2000-11-09 | Ut-Battelle, Llc | Method and apparatus for combinatorial chemistry |
US6225109B1 (en) * | 1999-05-27 | 2001-05-01 | Orchid Biosciences, Inc. | Genetic analysis device |
JP3469504B2 (ja) * | 1999-06-01 | 2003-11-25 | 日立ソフトウエアエンジニアリング株式会社 | マイクロアレイチップ及びそのインデックス方法 |
US6716579B1 (en) | 1999-06-11 | 2004-04-06 | Narayan Baidya | Gene specific arrays, preparation and use |
US6399394B1 (en) | 1999-06-30 | 2002-06-04 | Agilent Technologies, Inc. | Testing multiple fluid samples with multiple biopolymer arrays |
AU5785400A (en) * | 1999-07-02 | 2001-01-22 | Symyx Technologies, Inc. | Polymer brushes for immobilizing molecules to a surface or substrate, where the polymers have water-soluble or water-dispersible segments and probes bonded thereto |
US7022517B1 (en) | 1999-07-16 | 2006-04-04 | Board Of Regents, The University Of Texas System | Method and apparatus for the delivery of samples to a chemical sensor array |
US6346423B1 (en) | 1999-07-16 | 2002-02-12 | Agilent Technologies, Inc. | Methods and compositions for producing biopolymeric arrays |
US7144700B1 (en) | 1999-07-23 | 2006-12-05 | Affymetrix, Inc. | Photolithographic solid-phase polymer synthesis |
US6653151B2 (en) | 1999-07-30 | 2003-11-25 | Large Scale Proteomics Corporation | Dry deposition of materials for microarrays using matrix displacement |
US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
US6864050B2 (en) | 1999-07-30 | 2005-03-08 | Affymetrix, Inc. | Single-phase amplification of nucleic acids |
US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
US6994964B1 (en) | 1999-09-01 | 2006-02-07 | Affymetrix, Inc. | Macromolecular arrays on polymeric brushes and methods for preparing the same |
WO2001019516A1 (en) * | 1999-09-13 | 2001-03-22 | Hoffmann La Roche | Suspension handling system |
FR2798675B1 (fr) * | 1999-09-16 | 2004-02-27 | Centre Nat Rech Scient | Procede et dispositif de fabrication d'un support porteur d'une pluralite de sequences polynucleotidiques et/ou peptidiques differentes |
US7244559B2 (en) * | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7211390B2 (en) * | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US6649343B1 (en) * | 1999-10-22 | 2003-11-18 | Ngk Insulators, Ltd. | DNA chip and method for producing the same |
US6958225B2 (en) | 1999-10-27 | 2005-10-25 | Affymetrix, Inc. | Complexity management of genomic DNA |
US7448258B2 (en) * | 1999-10-29 | 2008-11-11 | Avery Dennison Corporation | High throughput screening for moisture barrier characteristics of materials |
US6689319B1 (en) * | 1999-10-29 | 2004-02-10 | Agilent Technologies, Ind. | Apparatus for deposition and inspection of chemical and biological fluids |
US6315958B1 (en) | 1999-11-10 | 2001-11-13 | Wisconsin Alumni Research Foundation | Flow cell for synthesis of arrays of DNA probes and the like |
US6680208B1 (en) * | 1999-11-19 | 2004-01-20 | Becton, Dickinson And Company | Rapid protein identification using antibody mixtures |
US6800439B1 (en) | 2000-01-06 | 2004-10-05 | Affymetrix, Inc. | Methods for improved array preparation |
WO2001055703A1 (en) * | 2000-01-31 | 2001-08-02 | Board Of Regents, The University Of Texas System | Method of preparing a sensor array |
EP1265641A2 (en) | 2000-02-22 | 2002-12-18 | Biostream, Inc. | Imaging agents for diagnosis of parkinson's disease |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
US6833450B1 (en) | 2000-03-17 | 2004-12-21 | Affymetrix, Inc. | Phosphite ester oxidation in nucleic acid array preparation |
US20050119473A1 (en) * | 2000-03-17 | 2005-06-02 | Affymetrix, Inc. | Phosphite ester oxidation in nucleic acid array preparation |
US6806361B1 (en) | 2000-03-17 | 2004-10-19 | Affymetrix, Inc. | Methods of enhancing functional performance of nucleic acid arrays |
JP2004500109A (ja) | 2000-03-22 | 2004-01-08 | クァンタム・ドット・コーポレイション | ビーズベースの核酸アッセイにおける半導体ナノクリスタルの使用方法 |
US6683108B1 (en) | 2000-03-30 | 2004-01-27 | Curis, Inc. | Agonists of hedgehog signaling pathways and uses related thereto |
US6613798B1 (en) | 2000-03-30 | 2003-09-02 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
US8852937B2 (en) | 2000-03-30 | 2014-10-07 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
US7115653B2 (en) | 2000-03-30 | 2006-10-03 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
US6884578B2 (en) * | 2000-03-31 | 2005-04-26 | Affymetrix, Inc. | Genes differentially expressed in secretory versus proliferative endometrium |
US20020081597A1 (en) * | 2000-03-31 | 2002-06-27 | Genentech, Inc. | Compositions and methods for detecting and quantifying gene expression |
US7157564B1 (en) | 2000-04-06 | 2007-01-02 | Affymetrix, Inc. | Tag nucleic acids and probe arrays |
CN1196798C (zh) | 2000-05-04 | 2005-04-13 | 耶鲁大学 | 用于筛选蛋白活性的高密度蛋白阵列 |
CA2344946A1 (en) * | 2000-05-10 | 2001-11-10 | Symyx Technologies, Inc. | Polymer libraries on a substrate, method of forming polymer libraries on a substrate and characterization methods with same |
WO2001090225A1 (fr) * | 2000-05-22 | 2001-11-29 | Kabushiki Kaisya Advance | Nouveau procede de preparation de composition polymere |
US6393898B1 (en) | 2000-05-25 | 2002-05-28 | Symyx Technologies, Inc. | High throughput viscometer and method of using same |
US6664067B1 (en) * | 2000-05-26 | 2003-12-16 | Symyx Technologies, Inc. | Instrument for high throughput measurement of material physical properties and method of using same |
US7005259B1 (en) * | 2000-06-01 | 2006-02-28 | Affymetrix, Inc. | Methods for array preparation using substrate rotation |
DE10027524A1 (de) * | 2000-06-02 | 2001-12-13 | Max Planck Gesellschaft | Vorrichtung und Verfahren zur Bearbeitung von substratgebundenen Proben |
DE60023464T2 (de) * | 2000-06-05 | 2006-07-20 | Stmicroelectronics S.R.L., Agrate Brianza | Verfahren zur Herstellung integrierter chemischer Mikroreaktoren aus Halbleitermaterial sowie integrierter Mikroreaktor |
CN1443074A (zh) | 2000-06-08 | 2003-09-17 | 血液研究中心 | 抑制免疫球蛋白介导的再灌注损伤的方法和组合物 |
AU2001268468A1 (en) | 2000-06-13 | 2001-12-24 | The Trustees Of Boston University | Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing |
US6455007B1 (en) * | 2000-06-13 | 2002-09-24 | Symyx Technologies, Inc. | Apparatus and method for testing compositions in contact with a porous medium |
US6468736B2 (en) | 2000-06-22 | 2002-10-22 | Atto Instruments, Llc. | High efficiency cell analysis system and high throughput drug screening system |
US20020115068A1 (en) * | 2000-06-23 | 2002-08-22 | Ian Tomlinson | Matrix screening method |
US20020055110A1 (en) * | 2000-06-23 | 2002-05-09 | Ian Tomlinson | Matrix screening method |
DK1292710T3 (da) * | 2000-06-23 | 2007-12-27 | Domantis Ltd | Fremgangsmåde til matrix-screening |
US6511277B1 (en) | 2000-07-10 | 2003-01-28 | Affymetrix, Inc. | Cartridge loader and methods |
US6596490B2 (en) | 2000-07-14 | 2003-07-22 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
US6380377B1 (en) | 2000-07-14 | 2002-04-30 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
AU2001280746A1 (en) | 2000-07-21 | 2002-02-05 | Phase-1 Molecular Toxicology | Canine toxicity genes |
US6422249B1 (en) | 2000-08-10 | 2002-07-23 | Affymetrix Inc. | Cartridge washing system and methods |
WO2002057200A2 (en) * | 2000-08-15 | 2002-07-25 | Bioforce Nanosciences, Inc. | Nanoscale molecular arrayer |
US7062092B2 (en) | 2000-08-22 | 2006-06-13 | Affymetrix, Inc. | System, method, and computer software product for gain adjustment in biological microarray scanner |
US6965704B2 (en) * | 2000-08-22 | 2005-11-15 | Affymetrix, Inc. | System, method, and computer software product for grid alignment of multiple scanned images |
AU3511802A (en) | 2000-08-22 | 2002-05-06 | Affymetrix, Inc. | System method, and computer software product for controlling biological microarray scanner |
US20020164634A1 (en) * | 2000-08-26 | 2002-11-07 | Perlegen Sciences, Inc. | Methods for reducing complexity of nucleic acid samples |
US7108969B1 (en) | 2000-09-08 | 2006-09-19 | Affymetrix, Inc. | Methods for detecting and diagnosing oral cancer |
CA2421732A1 (en) * | 2000-09-11 | 2002-03-14 | Affymetrix, Inc. | Photocleavable protecting groups |
US20040185464A1 (en) * | 2000-09-15 | 2004-09-23 | Kris Richard M. | High throughput assay system |
GB0022978D0 (en) | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
US20020061258A1 (en) * | 2000-09-25 | 2002-05-23 | Mutz Mitchell W. | Focused acoustic energy in the preparation and screening of combinatorial libraries |
US7900505B2 (en) | 2000-09-25 | 2011-03-08 | Labcyte Inc. | Acoustic assessment of fluids in a plurality of reservoirs |
US6727060B2 (en) | 2000-09-26 | 2004-04-27 | Health Research, Inc. | Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients |
US20030082604A1 (en) * | 2000-09-27 | 2003-05-01 | Swanson Melvin J. | High density arrays |
US20100261159A1 (en) * | 2000-10-10 | 2010-10-14 | Robert Hess | Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
AU9684601A (en) | 2000-10-12 | 2002-04-22 | Univ Rochester | Compositions that inhibit proliferation of cancer cells |
US6908732B2 (en) | 2000-10-13 | 2005-06-21 | President & Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
DE10051396A1 (de) * | 2000-10-17 | 2002-04-18 | Febit Ferrarius Biotech Gmbh | Verfahren und Vorrichtung zur integrierten Synthese und Analytbestimmung an einem Träger |
AU2002245047A1 (en) | 2000-10-30 | 2002-07-24 | Sequenom, Inc. | Method and apparatus for delivery of submicroliter volumes onto a substrate |
WO2002051549A2 (en) * | 2000-12-22 | 2002-07-04 | Amersham Biosciences (Sv) Corp. | High speed liquid deposition apparatus for microarray fabrication |
US20020123134A1 (en) * | 2000-12-26 | 2002-09-05 | Mingxian Huang | Active and biocompatible platforms prepared by polymerization of surface coating films |
WO2002056021A2 (en) * | 2001-01-10 | 2002-07-18 | Symyx Technologies Inc | Polymer brushes for immobilizing molecules to a surface |
US6918309B2 (en) * | 2001-01-17 | 2005-07-19 | Irm Llc | Sample deposition method and system |
JP2004533228A (ja) * | 2001-01-19 | 2004-11-04 | エジー バイオサイエンシーズ, インコーポレイテッド | 標的ポリペプチドをコードするポリヌクレオチドのコンピューターに従うアセンブリ |
WO2002063270A2 (en) * | 2001-02-05 | 2002-08-15 | Board Of Regents, The University Of Texas System | The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors |
US20020166592A1 (en) * | 2001-02-09 | 2002-11-14 | Shaorong Liu | Apparatus and method for small-volume fluid manipulation and transportation |
AU2002306486A1 (en) * | 2001-02-09 | 2002-08-28 | Microchem Solutions | Method and apparatus for sample injection in microfabricated devices |
US20020160527A1 (en) * | 2001-02-26 | 2002-10-31 | 3M Innovative Properties Company | Combinatorial library comprising pouches as packages for library members and method therefor |
JP4190290B2 (ja) | 2001-03-02 | 2008-12-03 | ユニバーシティー オブ ウエスタン オンタリオ | 放射能標識された化合物のポリマー前駆体、ならびにその作製および使用法 |
JP2002267667A (ja) * | 2001-03-08 | 2002-09-18 | Hitachi Software Eng Co Ltd | マイクロアレイ及びマイクロアレイ用基板 |
US20040076954A1 (en) * | 2001-03-12 | 2004-04-22 | Irm, Llc | Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters |
PT1423400E (pt) * | 2001-03-19 | 2006-12-29 | Harvard College | Evolução de nova função molecular |
US20040013573A1 (en) * | 2001-03-26 | 2004-01-22 | Tai-Nang Huang | Polymer synthesis apparatus |
US20020176927A1 (en) * | 2001-03-29 | 2002-11-28 | Kodas Toivo T. | Combinatorial synthesis of material systems |
US6596489B2 (en) | 2001-03-30 | 2003-07-22 | Applied Gene Technologies | Methods and compositions for analyzing nucleotide sequence mismatches using RNase H |
US7115726B2 (en) * | 2001-03-30 | 2006-10-03 | Perlegen Sciences, Inc. | Haplotype structures of chromosome 21 |
AU785425B2 (en) | 2001-03-30 | 2007-05-17 | Genetic Technologies Limited | Methods of genomic analysis |
US6727479B2 (en) | 2001-04-23 | 2004-04-27 | Stmicroelectronics S.R.L. | Integrated device based upon semiconductor technology, in particular chemical microreactor |
WO2002085838A1 (en) | 2001-04-24 | 2002-10-31 | Massachusetts Institute Of Technology | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
DE10121571A1 (de) * | 2001-04-26 | 2002-10-31 | Lifebits Ag | Festphasen-Synthese von Oligomeren |
US20020160427A1 (en) * | 2001-04-27 | 2002-10-31 | Febit Ag | Methods and apparatuses for electronic determination of analytes |
US7138506B2 (en) * | 2001-05-09 | 2006-11-21 | Genetic Id, Na, Inc. | Universal microarray system |
US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
WO2003000404A1 (en) * | 2001-06-22 | 2003-01-03 | Domantis Limited | Matrix screening method |
CA2453207A1 (en) * | 2001-07-06 | 2003-01-16 | 454 Corporation | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
AU2002327220A1 (en) * | 2001-07-10 | 2003-01-29 | Wisconsin Alumni Research Foundation | Surface plasmon resonance imaging of micro-arrays |
US20030013208A1 (en) * | 2001-07-13 | 2003-01-16 | Milagen, Inc. | Information enhanced antibody arrays |
US7297553B2 (en) * | 2002-05-28 | 2007-11-20 | Nanosphere, Inc. | Method for attachment of silylated molecules to glass surfaces |
US7687437B2 (en) | 2001-07-13 | 2010-03-30 | Nanosphere, Inc. | Method for immobilizing molecules onto surfaces |
US7348140B1 (en) | 2001-07-25 | 2008-03-25 | Acadia Pharmaceuticals, Inc. | Clinical indications for genotyping polymorphic variants of G-protein coupled receptors |
US20050019223A1 (en) * | 2001-08-10 | 2005-01-27 | Platt Albert Edward | Liquid delivery apparatus and method |
WO2003013718A1 (en) * | 2001-08-10 | 2003-02-20 | Oxford Glycosciences (Uk) Ltd | Liquid delivery apparatus and method |
US6663596B2 (en) | 2001-08-13 | 2003-12-16 | Scimed Life Systems, Inc. | Delivering material to a patient |
US20080026367A9 (en) * | 2001-08-17 | 2008-01-31 | Perlegen Sciences, Inc. | Methods for genomic analysis |
US6837115B2 (en) | 2001-08-24 | 2005-01-04 | Symyx Technologies, Inc. | High throughput mechanical rapid serial property testing of materials libraries |
US6736017B2 (en) | 2001-08-24 | 2004-05-18 | Symyx Technologies, Inc. | High throughput mechanical rapid serial property testing of materials libraries |
US6860148B2 (en) | 2001-08-24 | 2005-03-01 | Symyx Technologies, Inc. | High throughput fabric handle screening |
US6772642B2 (en) | 2001-08-24 | 2004-08-10 | Damian A. Hajduk | High throughput mechanical property and bulge testing of materials libraries |
US6857309B2 (en) | 2001-08-24 | 2005-02-22 | Symyx Technologies, Inc. | High throughput mechanical rapid serial property testing of materials libraries |
US6690179B2 (en) * | 2001-08-24 | 2004-02-10 | Symyx Technologies, Inc. | High throughput mechanical property testing of materials libraries using capacitance |
US6769292B2 (en) * | 2001-08-24 | 2004-08-03 | Symyx Technologies, Inc | High throughput rheological testing of materials |
US6650102B2 (en) | 2001-08-24 | 2003-11-18 | Symyx Technologies, Inc. | High throughput mechanical property testing of materials libraries using a piezoelectric |
US7666661B2 (en) | 2001-08-27 | 2010-02-23 | Platypus Technologies, Llc | Substrates, devices, and methods for quantitative liquid crystal assays |
US20050147984A1 (en) * | 2001-08-31 | 2005-07-07 | Clondiag Chip Technologies Gmbh | Interaction detection on several probe arrays |
US20030054396A1 (en) * | 2001-09-07 | 2003-03-20 | Weiner Michael P. | Enzymatic light amplification |
US6955788B2 (en) | 2001-09-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus and method for aligning microarray printing head |
US6974671B1 (en) | 2001-09-12 | 2005-12-13 | Salk Institute For Biological Studies | Methods for indentifying compounds that modulate gluconeogenesis through the binding of CREB to the PGC-1 promoter |
WO2003024923A1 (en) * | 2001-09-14 | 2003-03-27 | Axys Pharmaceuticals, Inc. | Sulfonamide compounds as protease inhibitors |
US20030055587A1 (en) * | 2001-09-17 | 2003-03-20 | Symyx Technologies, Inc. | Rapid throughput surface topographical analysis |
AU2002362446A1 (en) * | 2001-10-03 | 2003-04-14 | Kin Chiu Ng | Apparatus and method for fabricating high density microarrays and applications thereof |
US20040053232A1 (en) * | 2001-10-05 | 2004-03-18 | Perlegen Sciences, Inc. | Haplotype structures of chromosome 21 |
US6956114B2 (en) | 2001-10-30 | 2005-10-18 | '454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US20050124022A1 (en) * | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6902921B2 (en) * | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
CA2460283A1 (en) * | 2001-10-31 | 2003-05-08 | Pfizer Products Inc. | Therapeutics and diagnostics for disorders of erythropoiesis |
US20040023237A1 (en) * | 2001-11-26 | 2004-02-05 | Perelegen Sciences Inc. | Methods for genomic analysis |
US20050221283A1 (en) * | 2001-12-11 | 2005-10-06 | Mahant Vijay K | Biochip |
JP2005513457A (ja) * | 2001-12-19 | 2005-05-12 | アフィメトリックス インコーポレイテッド | アレイプレートおよびアレイプレートを構築するための方法 |
US6846454B2 (en) * | 2001-12-24 | 2005-01-25 | Agilent Technologies, Inc. | Fluid exit in reaction chambers |
US6790620B2 (en) * | 2001-12-24 | 2004-09-14 | Agilent Technologies, Inc. | Small volume chambers |
EP1323465A1 (en) * | 2001-12-31 | 2003-07-02 | Corning Incorporated | Flexible high density array print head with systems and methods for aligning pin plate, reservoir and substrate with respect to each other |
US7013709B2 (en) * | 2002-01-31 | 2006-03-21 | Symyx Technologies, Inc. | High throughput preparation and analysis of plastically shaped material samples |
US7157229B2 (en) | 2002-01-31 | 2007-01-02 | Nimblegen Systems, Inc. | Prepatterned substrate for optical synthesis of DNA probes |
AU2003209030B2 (en) | 2002-02-06 | 2009-02-05 | Stasys Technologies, Inc. | Anti-infarction molecules |
AU2003253580A1 (en) * | 2002-02-26 | 2003-11-17 | University Of Minnesota | Variants of nedd4l associated with hypertension and viral budding |
US6825229B2 (en) | 2002-03-07 | 2004-11-30 | Blanchette Rockefeller Neurosciences Institute | Methods for Alzheimer's Disease treatment and cognitive enhancement |
US20050065205A1 (en) | 2002-03-07 | 2005-03-24 | Daniel Alkon | Methods for Alzheimer's disease treatment and cognitive enhance |
EP2963017A1 (en) | 2002-03-11 | 2016-01-06 | Molecular Insight Pharmaceuticals, Inc. | Technetium-dipyridine complexes, and methods of use thereof |
CA2422224A1 (en) | 2002-03-15 | 2003-09-15 | Affymetrix, Inc. | System, method, and product for scanning of biological materials |
AU2003220487A1 (en) * | 2002-03-19 | 2003-10-08 | Cengent Therapeutics, Inc. | Discrete bayesian analysis of data |
US7473030B2 (en) | 2002-04-01 | 2009-01-06 | Palo Alto Research Center Incorporated | Thermal sensing |
US7473031B2 (en) * | 2002-04-01 | 2009-01-06 | Palo Alto Research Center, Incorporated | Resistive thermal sensing |
US7833800B2 (en) * | 2002-04-01 | 2010-11-16 | Palo Alto Research Center Incorporated | Thermal sensing with bridge circuitry |
US7754492B2 (en) * | 2002-04-01 | 2010-07-13 | Palo Alto Research Center Incorporated | Thermal sensing device |
US7147763B2 (en) * | 2002-04-01 | 2006-12-12 | Palo Alto Research Center Incorporated | Apparatus and method for using electrostatic force to cause fluid movement |
AU2003231032B2 (en) | 2002-04-22 | 2008-07-10 | Johns Hopkins University School Of Medicine | Modulators of hedgehog signaling pathways, compositions and uses related thereto |
AU2003228711C1 (en) * | 2002-04-26 | 2010-01-07 | Board Of Regents, The University Of Texas System | Method and system for the detection of cardiac risk factors |
US20030203500A1 (en) * | 2002-04-26 | 2003-10-30 | Symyx Technologies, Inc. | High throughput testing of fluid samples using an electric field |
US20040023275A1 (en) * | 2002-04-29 | 2004-02-05 | Perlegen Sciences, Inc. | Methods for genomic analysis |
EP2204181A3 (en) | 2002-04-30 | 2010-09-22 | Trustees Of Tufts College | Protease inhibitors |
US20030214553A1 (en) * | 2002-05-14 | 2003-11-20 | Microsoft Corporation | Ink regions in an overlay control |
EP1549953A4 (en) | 2002-05-22 | 2006-12-06 | Platypus Technologies Inc | SUBSTRATES, DEVICES AND METHOD FOR CELL TESTS |
US20030219755A1 (en) * | 2002-05-24 | 2003-11-27 | Nanibhushan Dattagupta | Compositions and methods for performing hybridization assays using target enhanced signal amplification (TESA) |
US7537936B2 (en) * | 2002-05-31 | 2009-05-26 | Agilent Technologies, Inc. | Method of testing multiple fluid samples with multiple biopolymer arrays |
US20030232379A1 (en) * | 2002-06-14 | 2003-12-18 | Amorese Douglas A. | Methods of performing array based assays and compositions for practicing the same |
US7144950B2 (en) | 2003-09-17 | 2006-12-05 | The Regents Of The University Of California | Conformationally flexible cationic conjugated polymers |
US7332273B2 (en) | 2002-06-20 | 2008-02-19 | Affymetrix, Inc. | Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays |
ATE476521T1 (de) | 2002-06-20 | 2010-08-15 | Univ California | Verfahren und zusammensetzungen zum nachweis und zur analyse von polynukleotiden unter verwendung von licht einfangenden multichromophoren |
US7442342B2 (en) * | 2002-06-26 | 2008-10-28 | Ge Healthcare Bio-Sciences Ab | Biochip holder and method of collecting fluid |
US20040009482A1 (en) * | 2002-07-09 | 2004-01-15 | Nanibhushan Dattagupta | Compositions and methods for detecting streptococcus agalactiae surface immunogenic protein genes |
US20040009574A1 (en) * | 2002-07-09 | 2004-01-15 | Nanibhushan Dattagupta | Compositions and methods for detecting streptococcus agalactiae capsular polysaccharide synthesis genes |
US7504215B2 (en) | 2002-07-12 | 2009-03-17 | Affymetrix, Inc. | Nucleic acid labeling methods |
EP1385006A3 (en) * | 2002-07-24 | 2004-09-01 | F. Hoffmann-La Roche Ag | System and cartridge for processing a biological sample |
US7632916B2 (en) | 2002-08-02 | 2009-12-15 | 3M Innovative Properties Company | Process to modify polymeric materials and resulting compositions |
AU2003257109A1 (en) * | 2002-08-05 | 2004-02-23 | Invitrogen Corporation | Compositions and methods for molecular biology |
AU2003257181A1 (en) | 2002-08-05 | 2004-02-23 | University Of Rochester | Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
US20060073475A1 (en) * | 2002-08-09 | 2006-04-06 | Nanibhushan Dattagupta | Compositions and methods for detecting pathogenic bacteria expressing chaperonin proteins |
US20050233473A1 (en) * | 2002-08-16 | 2005-10-20 | Zyomyx, Inc. | Methods and reagents for surface functionalization |
AU2003263937B2 (en) * | 2002-08-19 | 2010-04-01 | The President And Fellows Of Harvard College | Evolving new molecular function |
JP4504821B2 (ja) | 2002-08-26 | 2010-07-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 集光性多発色団を用いてポリヌクレオチドを検出及び分析するための方法並びに組成物 |
US7279134B2 (en) * | 2002-09-17 | 2007-10-09 | Intel Corporation | Microfluidic devices with porous membranes for molecular sieving, metering, and separations |
US20040123650A1 (en) * | 2002-09-17 | 2004-07-01 | Symyx Technologies, Inc. | High throughput rheological testing of materials |
AU2003270898A1 (en) * | 2002-09-27 | 2004-04-19 | Nimblegen Systems, Inc. | Microarray with hydrophobic barriers |
JP4471927B2 (ja) * | 2002-09-30 | 2010-06-02 | ニンブルゲン システムズ インコーポレイテッド | アレイの並列装填方法 |
US20040110212A1 (en) * | 2002-09-30 | 2004-06-10 | Mccormick Mark | Microarrays with visual alignment marks |
WO2004031351A2 (en) * | 2002-10-01 | 2004-04-15 | Nimblegen Systems, Inc. | Microarrays having multiple oligonucleotides in single array features |
US20050003369A1 (en) * | 2002-10-10 | 2005-01-06 | Affymetrix, Inc. | Method for depleting specific nucleic acids from a mixture |
US7112443B2 (en) * | 2002-10-18 | 2006-09-26 | Symyx Technologies, Inc. | High throughput permeability testing of materials libraries |
US20040081966A1 (en) * | 2002-10-25 | 2004-04-29 | Peck Bill J. | Chemical array linking layers |
US7341865B1 (en) * | 2002-10-25 | 2008-03-11 | Perlegen Sciences, Inc. | Liquid delivery devices and methods |
US6987897B2 (en) * | 2002-10-31 | 2006-01-17 | Luna Innovations Incorporated | Fiber-optic flow cell and method relating thereto |
WO2004041192A2 (en) * | 2002-10-31 | 2004-05-21 | Pfizer Products, Inc. | Panels of molecular targets differentially expressed during cd8+ t-cell priming |
AU2002952696A0 (en) | 2002-11-14 | 2002-11-28 | Genomics Research Partners Pty Ltd | Status determination |
EP1908850B1 (en) * | 2002-11-22 | 2012-01-04 | The Johns Hopkins University | Target for therapy of cognitive impairment |
EP1424599B1 (en) * | 2002-11-29 | 2008-03-12 | ASML Netherlands B.V. | Lithographic apparatus and device manufacturing method |
JP5138890B2 (ja) | 2002-12-09 | 2013-02-06 | マサチューセッツ インスティテュート オブ テクノロジー | 金属に対する配位子、および該配位子に基づく金属触媒プロセス |
US20040126766A1 (en) * | 2002-12-26 | 2004-07-01 | Amorese Douglas A. | Breakaway seal for processing a subarray of an array |
US7419638B2 (en) | 2003-01-14 | 2008-09-02 | Micronics, Inc. | Microfluidic devices for fluid manipulation and analysis |
US8081792B2 (en) | 2003-08-20 | 2011-12-20 | Illumina, Inc. | Fourier scattering methods for encoding microbeads and methods and apparatus for reading the same |
AU2004209001B2 (en) * | 2003-01-29 | 2007-10-11 | 454 Life Sciences Corporation | Bead emulsion nucleic acid amplification |
US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
EP2351856A1 (en) | 2003-02-13 | 2011-08-03 | The Regents Of the University of California | Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores |
US20040166124A1 (en) * | 2003-02-25 | 2004-08-26 | Dunfield John Stephen | Fluid-jet pens configured for making modulated release bioactive agents |
US20060183132A1 (en) * | 2005-02-14 | 2006-08-17 | Perlegen Sciences, Inc. | Selection probe amplification |
US20090124514A1 (en) * | 2003-02-26 | 2009-05-14 | Perlegen Sciences, Inc. | Selection probe amplification |
US20040235019A1 (en) * | 2003-03-06 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Diagnostics and therapeutics for the gene expression signature of PPAR-gamma receptor ligand |
US6970240B2 (en) * | 2003-03-10 | 2005-11-29 | Applera Corporation | Combination reader |
US7713485B2 (en) * | 2003-03-19 | 2010-05-11 | Industrial Technology Research Institute | Microfluidics switch with moving planes |
US8017323B2 (en) * | 2003-03-26 | 2011-09-13 | President And Fellows Of Harvard College | Free reactant use in nucleic acid-templated synthesis |
JP2006523444A (ja) | 2003-04-14 | 2006-10-19 | ノバルティス アクチエンゲゼルシャフト | 骨芽細胞分化に関連する遺伝子発現 |
WO2004098650A2 (en) | 2003-05-02 | 2004-11-18 | The University Of Western Ontario | Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |
AU2003229474A1 (en) * | 2003-05-09 | 2004-11-26 | Capital Biochip Company, Ltd. | Methods and compositions for detecting sars virus |
US9317922B2 (en) | 2003-05-16 | 2016-04-19 | Board Of Regents The University Of Texas System | Image and part recognition technology |
US7651850B2 (en) * | 2003-05-16 | 2010-01-26 | Board Of Regents, The University Of Texas System | Image and part recognition technology |
US20040241659A1 (en) * | 2003-05-30 | 2004-12-02 | Applera Corporation | Apparatus and method for hybridization and SPR detection |
US20040248323A1 (en) | 2003-06-09 | 2004-12-09 | Protometrix, Inc. | Methods for conducting assays for enzyme activity on protein microarrays |
WO2005000098A2 (en) | 2003-06-10 | 2005-01-06 | The Trustees Of Boston University | Detection methods for disorders of the lung |
US8133670B2 (en) * | 2003-06-13 | 2012-03-13 | Cold Spring Harbor Laboratory | Method for making populations of defined nucleic acid molecules |
US8034303B2 (en) | 2003-06-20 | 2011-10-11 | Universal Bio Research Co., Ltd. | Sample arraying/assembling device, its method, and apparatus using sample assembly |
US20040259100A1 (en) | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
DK1636586T3 (da) * | 2003-06-24 | 2009-11-23 | Ventana Med Syst Inc | Enzymkatalyseret metaldeponering til foröget in situ-detektion af immunhistokemisker epitoper og nucleinsyresekvenser |
US7642064B2 (en) | 2003-06-24 | 2010-01-05 | Ventana Medical Systems, Inc. | Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest |
US7534563B2 (en) * | 2003-06-30 | 2009-05-19 | Agilent Technologies, Inc. | Methods for producing ligand arrays |
CN100494399C (zh) * | 2003-06-30 | 2009-06-03 | 清华大学 | 一种基于dna芯片的基因分型方法及其应用 |
JP4950663B2 (ja) | 2003-07-25 | 2012-06-13 | プラティパス テクノロジーズ エルエルシー | 液晶ベースの分析物検出 |
IL157206A0 (en) * | 2003-08-03 | 2004-02-19 | Correlating spatial position of chemical species on a substrate with molecular weight, structure and chemical reactivity | |
US20050100911A1 (en) * | 2003-08-06 | 2005-05-12 | Perlegen Sciences, Inc. | Methods for enriching populations of nucleic acid samples |
CN1580283A (zh) * | 2003-08-13 | 2005-02-16 | 清华大学 | 一种检测核酸分子的方法 |
CA2535971C (en) | 2003-08-20 | 2018-04-10 | Biosite, Inc. | Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential |
US8131475B2 (en) | 2003-09-03 | 2012-03-06 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Methods for identifying, diagnosing, and predicting survival of lymphomas |
EP2157524A3 (en) | 2003-09-03 | 2010-12-08 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Methods for identifying, diagnosing, and predicting survival of lymphomas |
DE602004011244T2 (de) * | 2003-09-23 | 2009-02-12 | Wisconsin Alumni Research Foundation, Madison | Verwendung von flüssigkristallen zum nachweis von affinitätsmikrokontakt-gedruckten biomolekülen |
US7795007B2 (en) | 2003-09-23 | 2010-09-14 | Wisconsin Alumni Research Foundation | Detection of post-translationally modified peptides with liquid crystals |
US20050227251A1 (en) | 2003-10-23 | 2005-10-13 | Robert Darnell | Method of purifying RNA binding protein-RNA complexes |
US20050277125A1 (en) * | 2003-10-27 | 2005-12-15 | Massachusetts Institute Of Technology | High-density reaction chambers and methods of use |
FR2861608B1 (fr) * | 2003-10-31 | 2005-12-23 | Commissariat Energie Atomique | Dispositif de travail comportant des zones de travail bordees, laboratoire sur puce et microsysteme |
FR2861609B1 (fr) * | 2003-10-31 | 2006-02-03 | Commissariat Energie Atomique | Procede de repartition de gouttes d'un liquide d'interet sur une surface |
US20070207055A1 (en) * | 2003-10-31 | 2007-09-06 | Commissariat A L'energie Atomique | Operating Device Comprising A Localized Zone For The Capture Of A Drop A Liquid Of Interest |
CA2545482A1 (en) | 2003-11-10 | 2005-05-26 | Platypus Technologies, Llc | Substrates, devices, and methods for cellular assays |
EP1709198B1 (en) | 2003-11-26 | 2013-08-14 | AdvanDx, Inc. | Peptide nucleic acid probes for analysis of certain staphylococcus species |
CA2549190A1 (en) | 2003-12-11 | 2005-06-30 | Board Of Regents, The University Of Texas System | Method and system for the analysis of saliva using a sensor array |
CA2497324A1 (en) | 2004-02-17 | 2005-08-17 | Affymetrix, Inc. | Methods for fragmenting and labelling dna |
EP2388017B1 (en) | 2004-02-24 | 2014-12-24 | The General Hospital Corporation | Catalytic radiofluorination |
WO2005082110A2 (en) * | 2004-02-26 | 2005-09-09 | Illumina Inc. | Haplotype markers for diagnosing susceptibility to immunological conditions |
US8105849B2 (en) | 2004-02-27 | 2012-01-31 | Board Of Regents, The University Of Texas System | Integration of fluids and reagents into self-contained cartridges containing sensor elements |
US8101431B2 (en) | 2004-02-27 | 2012-01-24 | Board Of Regents, The University Of Texas System | Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems |
EP2290077B1 (en) | 2004-03-01 | 2016-01-27 | Immune Disease Institute, Inc. | Natural IGM antibodies and inhibitors thereof |
ATE549625T1 (de) | 2004-03-24 | 2012-03-15 | Tripath Imaging Inc | Verfahren und zusammensetzungen zum nachweis einer zervixerkrankung |
DE602005007591D1 (de) * | 2004-04-21 | 2008-07-31 | Pamgene Bv | Maskierte feste träger |
JP2007535681A (ja) * | 2004-04-30 | 2007-12-06 | バイオフォース・ナノサイエンシィズ・インコーポレーテッド | 物質を表面上に堆積させるための方法と装置 |
US20060010513A1 (en) * | 2004-05-11 | 2006-01-12 | Melville Mark W | Oligonucleotide arrays to monitor gene expression and methods for making and using same |
TW200538181A (en) | 2004-05-18 | 2005-12-01 | Brni Neurosciences Inst | Treatment of depressive disorders |
US8034553B2 (en) | 2004-06-24 | 2011-10-11 | Kimberly-Clark Worldwide, Inc. | Biomarkers for wound healing |
US7702466B1 (en) | 2004-06-29 | 2010-04-20 | Illumina, Inc. | Systems and methods for selection of nucleic acid sequence probes |
US20060000709A1 (en) * | 2004-06-30 | 2006-01-05 | Sebastian Bohm | Methods for modulation of flow in a flow pathway |
US20060002817A1 (en) * | 2004-06-30 | 2006-01-05 | Sebastian Bohm | Flow modulation devices |
US20060001551A1 (en) * | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Analyte monitoring system with wireless alarm |
US8343074B2 (en) * | 2004-06-30 | 2013-01-01 | Lifescan Scotland Limited | Fluid handling devices |
US20070207057A1 (en) * | 2004-07-12 | 2007-09-06 | Arkray, Inc. | Analyzer, Method for Specifying Reaction Vessel in Analyzer, and Analytical Apparatus |
JP2006038460A (ja) * | 2004-07-22 | 2006-02-09 | Olympus Corp | 基板固定装置及びこれを備えた試験片の製造装置並びに試験片の製造方法 |
US7342093B2 (en) | 2004-07-23 | 2008-03-11 | University Of Massachusetts | Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
EP1782075B1 (en) * | 2004-08-04 | 2023-10-04 | Life Technologies Corporation | Method for differentially coating a substrate |
US20060105453A1 (en) | 2004-09-09 | 2006-05-18 | Brenan Colin J | Coating process for microfluidic sample arrays |
US7763708B2 (en) * | 2004-08-12 | 2010-07-27 | Institute For Protein Science Co., Ltd. | Methods and compositions for modulating C5-a-mediated inflammatory responses |
KR100657895B1 (ko) | 2004-08-17 | 2006-12-14 | 삼성전자주식회사 | 잉크젯 방식의 마이크로어레이 제작용 스폿팅 장치 및이를 이용한 스폿팅 방법 |
WO2006023312A2 (en) | 2004-08-20 | 2006-03-02 | Carl Deirmengian | Diagnostic assay for source of inflammation |
FI20041204A0 (fi) | 2004-09-16 | 2004-09-16 | Riikka Lund | Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi |
US8084400B2 (en) * | 2005-10-11 | 2011-12-27 | Intermolecular, Inc. | Methods for discretized processing and process sequence integration of regions of a substrate |
US20060073506A1 (en) | 2004-09-17 | 2006-04-06 | Affymetrix, Inc. | Methods for identifying biological samples |
US7749881B2 (en) * | 2005-05-18 | 2010-07-06 | Intermolecular, Inc. | Formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region |
US7390739B2 (en) * | 2005-05-18 | 2008-06-24 | Lazovsky David E | Formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region |
US20060060301A1 (en) * | 2004-09-17 | 2006-03-23 | Lazovsky David E | Substrate processing using molecular self-assembly |
US20060292846A1 (en) * | 2004-09-17 | 2006-12-28 | Pinto Gustavo A | Material management in substrate processing |
US8882914B2 (en) * | 2004-09-17 | 2014-11-11 | Intermolecular, Inc. | Processing substrates using site-isolated processing |
US20060073511A1 (en) | 2004-10-05 | 2006-04-06 | Affymetrix, Inc. | Methods for amplifying and analyzing nucleic acids |
US20060078895A1 (en) * | 2004-10-12 | 2006-04-13 | Peck Bill J | Methods for in situ generation of nucleic acid arrays |
US7682782B2 (en) | 2004-10-29 | 2010-03-23 | Affymetrix, Inc. | System, method, and product for multiple wavelength detection using single source excitation |
JP2006126204A (ja) | 2004-10-29 | 2006-05-18 | Affymetrix Inc | ポリマーアレイを製造するための自動化方法 |
US7879710B2 (en) * | 2005-05-18 | 2011-02-01 | Intermolecular, Inc. | Substrate processing including a masking layer |
US7309658B2 (en) * | 2004-11-22 | 2007-12-18 | Intermolecular, Inc. | Molecular self-assembly in substrate processing |
DE102004056980A1 (de) * | 2004-11-25 | 2006-06-01 | Clondiag Chip Technologies Gmbh | Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern |
NL1027633C2 (nl) * | 2004-12-01 | 2006-06-02 | Stichting Tech Wetenschapp | Werkwijzen en mengsel voor (bio)chemische analyse en synthese. |
US7647186B2 (en) * | 2004-12-07 | 2010-01-12 | Illumina, Inc. | Oligonucleotide ordering system |
EP1831439A4 (en) * | 2004-12-10 | 2011-05-04 | Zellchip Technologies Inc | ORDERED OR MICROFLUIDIC MICROECHANTILL GAMBLING SETS AND METHODS OF MANUFACTURING AND USING THESE SETS |
US8338093B2 (en) * | 2004-12-31 | 2012-12-25 | Affymetrix, Inc. | Primer array synthesis and validation |
US7547775B2 (en) | 2004-12-31 | 2009-06-16 | Affymetrix, Inc. | Parallel preparation of high fidelity probes in an array format |
EP2502946B1 (en) | 2005-01-10 | 2017-10-04 | The Regents of The University of California | Cationic conjugated polymers suitable for strand-specific polynucleiotide detection in homogeneous and solid state assays |
WO2006102557A2 (en) | 2005-03-22 | 2006-09-28 | The President And Fellows Of Harvard College | Treatment of protein degradation disorders |
JP5129119B2 (ja) | 2005-04-05 | 2013-01-23 | コーニング インコーポレイテッド | 標識フリーバイオセンサおよび細胞 |
AU2006236621B2 (en) | 2005-04-14 | 2011-10-06 | The Trustees Of Boston University | Diagnostic for lung disorders using class prediction |
EP2392328A1 (en) | 2005-05-09 | 2011-12-07 | Hydra Biosciences, Inc. | Compounds for modulating TRPV3 Function |
PT1889065E (pt) | 2005-05-18 | 2013-09-27 | Novartis Ag | Métodos para o diagnóstico e tratamento de doenças tendo uma componente autoimune e/ou inflamatória |
EP2371843B1 (en) | 2005-05-19 | 2014-09-17 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof |
US8263414B2 (en) * | 2005-05-23 | 2012-09-11 | Siemens Healthcare Diagnostics Inc. | Dispensing of a diagnostic liquid onto a diagnostic reagent |
AU2006309284B2 (en) | 2005-05-31 | 2012-08-02 | Board Of Regents, The University Of Texas System | Methods and compositions related to determination and use of white blood cell counts |
US8445194B2 (en) | 2005-06-15 | 2013-05-21 | Callida Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
KR20130122630A (ko) | 2005-07-29 | 2013-11-07 | 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 | 단독의 또는 pkc 억제제와 배합된 pkc 활성화제의 장기 기억 향상을 위한 용도 |
US7662572B2 (en) | 2005-08-25 | 2010-02-16 | Platypus Technologies, Llc. | Compositions and liquid crystals |
CA2624900A1 (en) | 2005-10-04 | 2007-04-19 | The Research Foundation Of State University Of New York | Fibronectin polypeptides and methods of use |
WO2007044566A2 (en) * | 2005-10-07 | 2007-04-19 | Baylor Research Institute | Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis |
US7955436B2 (en) * | 2006-02-24 | 2011-06-07 | Intermolecular, Inc. | Systems and methods for sealing in site-isolated reactors |
US8776717B2 (en) * | 2005-10-11 | 2014-07-15 | Intermolecular, Inc. | Systems for discretized processing of regions of a substrate |
US7902063B2 (en) * | 2005-10-11 | 2011-03-08 | Intermolecular, Inc. | Methods for discretized formation of masking and capping layers on a substrate |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
US7964577B2 (en) * | 2005-10-14 | 2011-06-21 | Donald Carlton D | Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
WO2007111681A2 (en) * | 2005-10-31 | 2007-10-04 | Wisconsin Alumni Research Foundation | Device and methods for liquid crystal-based bioagent detection |
US20070099288A1 (en) * | 2005-11-02 | 2007-05-03 | Affymetrix, Inc. | Microfluidic Methods, Devices, and Systems for Fluid Handling |
US20080038714A1 (en) * | 2005-11-02 | 2008-02-14 | Affymetrix, Inc. | Instrument to Pneumatically Control Lab Cards and Method Thereof |
US8007267B2 (en) * | 2005-11-02 | 2011-08-30 | Affymetrix, Inc. | System and method for making lab card by embossing |
US20080311585A1 (en) * | 2005-11-02 | 2008-12-18 | Affymetrix, Inc. | System and method for multiplex liquid handling |
US8075852B2 (en) | 2005-11-02 | 2011-12-13 | Affymetrix, Inc. | System and method for bubble removal |
US7576037B2 (en) | 2005-11-18 | 2009-08-18 | Mei Technologies, Inc. | Process and apparatus for combinatorial synthesis |
WO2007061981A2 (en) * | 2005-11-21 | 2007-05-31 | Lumera Corporation | Surface plasmon resonance spectrometer with an actuator-driven angle scanning mechanism |
US7329860B2 (en) | 2005-11-23 | 2008-02-12 | Illumina, Inc. | Confocal imaging methods and apparatus |
US7463358B2 (en) | 2005-12-06 | 2008-12-09 | Lumera Corporation | Highly stable surface plasmon resonance plates, microarrays, and methods |
US7634363B2 (en) * | 2005-12-07 | 2009-12-15 | Affymetrix, Inc. | Methods for high throughput genotyping |
WO2007069882A1 (en) * | 2005-12-13 | 2007-06-21 | Erasmus University Medical Center Rotterdam | Genetic brain tumor markers |
US20070161031A1 (en) * | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
US20070255054A1 (en) * | 2005-12-30 | 2007-11-01 | Affymetrix, Inc. | Oligonucleotide synthesis with intermittent and post synthetic oxidation |
CA2637600A1 (en) | 2006-01-17 | 2007-07-26 | Health Research, Inc. | Heteroduplex tracking assay |
WO2007087377A2 (en) * | 2006-01-25 | 2007-08-02 | Massachusetts Institute Of Technology | Photoelectrochemical synthesis of high density combinatorial polymer arrays |
ATE548656T1 (de) | 2006-01-27 | 2012-03-15 | Tripath Imaging Inc | Verfahren zur identifizierung von patienten mit erhöhter wahrscheinlichkeit des auftretens eines ovarialkarzinoms und zusammensetzungen dafür |
US9445025B2 (en) | 2006-01-27 | 2016-09-13 | Affymetrix, Inc. | System, method, and product for imaging probe arrays with small feature sizes |
US8772772B2 (en) * | 2006-05-18 | 2014-07-08 | Intermolecular, Inc. | System and method for increasing productivity of combinatorial screening |
WO2007095194A2 (en) * | 2006-02-10 | 2007-08-23 | Intermolecular, Inc. | Method and apparatus for combinatorially varying materials, unit process and process sequence |
AU2007345292B2 (en) | 2006-02-14 | 2013-10-31 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
AU2007214458C1 (en) | 2006-02-14 | 2012-12-06 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase inhibitors |
AU2007223788B2 (en) | 2006-03-09 | 2012-11-29 | The Trustees Of Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
AU2007227224A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Anti-tumor cell antigen antibody therapeutics |
US20070231823A1 (en) * | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
US20070224616A1 (en) * | 2006-03-24 | 2007-09-27 | Erdogan Gulari | Method for forming molecular sequences on surfaces |
US7914988B1 (en) | 2006-03-31 | 2011-03-29 | Illumina, Inc. | Gene expression profiles to predict relapse of prostate cancer |
US7830575B2 (en) | 2006-04-10 | 2010-11-09 | Illumina, Inc. | Optical scanner with improved scan time |
WO2007130434A2 (en) * | 2006-05-02 | 2007-11-15 | Applera Corporation | Variable volume dispenser and method |
EP2019674B1 (en) | 2006-05-03 | 2016-11-23 | The President and Fellows of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
US20090263798A1 (en) * | 2006-05-15 | 2009-10-22 | Generation Biotech, Llc | Method For Identification Of Novel Physical Linkage Of Genomic Sequences |
US7674924B2 (en) * | 2006-05-22 | 2010-03-09 | Third Wave Technologies, Inc. | Compositions, probes, and conjugates and uses thereof |
US11001881B2 (en) | 2006-08-24 | 2021-05-11 | California Institute Of Technology | Methods for detecting analytes |
EP2029775B1 (en) * | 2006-06-05 | 2014-10-15 | California Institute Of Technology | Real time micro arrays |
WO2008013918A2 (en) | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
US8048626B2 (en) | 2006-07-28 | 2011-11-01 | California Institute Of Technology | Multiplex Q-PCR arrays |
US11525156B2 (en) | 2006-07-28 | 2022-12-13 | California Institute Of Technology | Multiplex Q-PCR arrays |
US7842499B2 (en) * | 2006-08-07 | 2010-11-30 | Platypus Technologies, Llc | Substrates, devices, and methods for cellular assays |
AU2007282219B2 (en) | 2006-08-07 | 2013-06-20 | Nsure Holding B.V. | Quality control of agricultural products based on gene expression |
EP2057277B1 (en) | 2006-08-07 | 2018-06-13 | Platypus Technologies, LLC | Substrates, devices, and methods for cellular assays |
JP5244103B2 (ja) | 2006-08-09 | 2013-07-24 | ホームステッド クリニカル コーポレイション | 器官特異的蛋白質およびその使用方法 |
US11560588B2 (en) | 2006-08-24 | 2023-01-24 | California Institute Of Technology | Multiplex Q-PCR arrays |
JP2010501577A (ja) | 2006-08-24 | 2010-01-21 | サーフェイス ロジックス,インコーポレイティド | 薬物動態が改善された化合物 |
CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
CA2664383C (en) | 2006-09-19 | 2017-08-22 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
CA2981308C (en) | 2006-09-21 | 2020-12-22 | University Of Rochester | Compositions and methods related to protein displacement therapy for myotonic dystrophy |
EP2164988B1 (en) | 2006-10-06 | 2016-02-17 | Sirigen Inc. | Fluorescent methods and materials for directed biomarker signal amplification |
US9845494B2 (en) | 2006-10-18 | 2017-12-19 | Affymetrix, Inc. | Enzymatic methods for genotyping on arrays |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
US8999317B2 (en) | 2006-11-01 | 2015-04-07 | University Of Rochester | Methods and compositions related to the structure and function of APOBEC3G |
WO2008066655A2 (en) | 2006-11-02 | 2008-06-05 | Yale University | Assessment of oocyte competence |
US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
KR20090078365A (ko) | 2006-11-03 | 2009-07-17 | 베일러 리서치 인스티튜트 | 혈액 백혈구 마이크로어레이 분석을 통한 전이성 흑색종의 진단 및 면역억제 지표의 모니터링 |
US20080242560A1 (en) * | 2006-11-21 | 2008-10-02 | Gunderson Kevin L | Methods for generating amplified nucleic acid arrays |
US8293684B2 (en) * | 2006-11-29 | 2012-10-23 | Exiqon | Locked nucleic acid reagents for labelling nucleic acids |
US8011317B2 (en) * | 2006-12-29 | 2011-09-06 | Intermolecular, Inc. | Advanced mixing system for integrated tool having site-isolated reactors |
US20100248975A1 (en) * | 2006-12-29 | 2010-09-30 | Gunjan Tiwari | Fluorogenic peptide substrate arrays for highly multiplexed, real-time monitoring of kinase activities |
CA2674378A1 (en) | 2007-01-03 | 2008-07-17 | Burnham Institute For Medical Research | Methods and compositions related to clot binding compounds |
US8642295B2 (en) | 2007-01-11 | 2014-02-04 | Erasmus University Medical Center | Circular chromosome conformation capture (4C) |
EP2596799B1 (en) | 2007-02-08 | 2016-11-23 | University of Utah Research Foundation | Methods and compositions related to inhibition of viral entry |
CN101848726A (zh) | 2007-02-09 | 2010-09-29 | 布朗歇特洛克菲勒神经科学研究所 | 苔藓抑素、苔藓抑素类似物和其它相关物质对头部创伤引起的记忆缺陷和脑损伤的疗效 |
JP5872138B2 (ja) | 2007-02-09 | 2016-03-01 | ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート | 虚血/卒中誘導性の記憶障害および脳障害におけるブリオスタチン、ブリオログ、および他の関連物質の治療効果 |
EP1961825A1 (en) | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Method for predicting the occurrence of metastasis in breast cancer patients |
EP2135080A4 (en) * | 2007-03-08 | 2010-12-01 | Switchgear Genomics | FUNCTIONAL ARRAYS FOR CHARACTERIZATION WITH HIGH PASSAGE OF REGULATORY ELEMENTS IN NONTRANSLATED SURFACES OF GENES |
US20080241831A1 (en) * | 2007-03-28 | 2008-10-02 | Jian-Bing Fan | Methods for detecting small RNA species |
JP2008256376A (ja) * | 2007-03-30 | 2008-10-23 | Fujifilm Corp | 検体の検出方法及びバイオチップ |
AU2008239594B2 (en) | 2007-04-13 | 2013-10-24 | Beth Israel Deaconess Medical Center | Methods for treating cancer resistant to ErbB therapeutics |
US8200440B2 (en) | 2007-05-18 | 2012-06-12 | Affymetrix, Inc. | System, method, and computer software product for genotype determination using probe array data |
US20100093554A1 (en) * | 2007-06-01 | 2010-04-15 | Keting Chu | Methods for identifying biomarkers, autoantibody signatures, and stratifying subject groups using peptide arrays |
CA2690734A1 (en) | 2007-06-14 | 2008-12-24 | Richard A. Clark | Polypeptides and methods of use |
US7960313B2 (en) * | 2007-06-14 | 2011-06-14 | Intermolecular, Inc. | Combinatorial processing including stirring |
US8067164B2 (en) | 2007-08-12 | 2011-11-29 | Integrated Dna Technologies, Inc. | Microarray system with improved sequence specificity |
US7785172B2 (en) * | 2007-08-14 | 2010-08-31 | Intermolecular, Inc. | Combinatorial processing including rotation and movement within a region |
US9968935B2 (en) * | 2007-08-20 | 2018-05-15 | Platypus Technologies, Llc | Devices for cell assays |
US20090060786A1 (en) * | 2007-08-29 | 2009-03-05 | Gibum Kim | Microfluidic apparatus for wide area microarrays |
US20090180931A1 (en) | 2007-09-17 | 2009-07-16 | Sequenom, Inc. | Integrated robotic sample transfer device |
EP2257802A4 (en) * | 2008-02-29 | 2014-07-02 | Univ Northwestern | BARRIERS TO FACILITATE BIOLOGICAL REACTIONS |
KR101030476B1 (ko) | 2008-03-11 | 2011-04-25 | 국립암센터 | Snp 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법 |
US8039817B2 (en) | 2008-05-05 | 2011-10-18 | Illumina, Inc. | Compensator for multiple surface imaging |
US20110105356A1 (en) * | 2008-05-07 | 2011-05-05 | Derosier Chad F | Compositions and methods for providing substances to and from an array |
US8472683B2 (en) * | 2008-05-09 | 2013-06-25 | General Electric Company | Motion correction in tomographic images |
AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
SI2297359T1 (sl) | 2008-05-30 | 2014-05-30 | The University Of North Carolina At Chapel Hill | Profili genskega izraĹľanja za napovedovanje izida raka dojke |
US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
CA2725599A1 (en) | 2008-05-30 | 2009-12-03 | The University Of British Columbia | Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling |
WO2009149359A2 (en) | 2008-06-06 | 2009-12-10 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Survival predictor for diffuse large b cell lymphoma |
US9682372B2 (en) * | 2008-06-19 | 2017-06-20 | Carterra, Inc. | Tip overlay for continuous flow spotting apparatus |
AU2009274549B2 (en) | 2008-07-23 | 2014-05-01 | Dana-Farber Cancer Institute, Inc. | Deacetylase inhibitors and uses thereof |
US8816095B2 (en) * | 2008-08-15 | 2014-08-26 | Georgetown University | Na channels, disease, and related assays and compositions |
WO2010031047A2 (en) * | 2008-09-15 | 2010-03-18 | Platypus Technologies, Llc | Detection of vapor phase compounds by changes in physical properties of a liquid crystal |
US8318439B2 (en) | 2008-10-03 | 2012-11-27 | Micronics, Inc. | Microfluidic apparatus and methods for performing blood typing and crossmatching |
US20100087325A1 (en) * | 2008-10-07 | 2010-04-08 | Illumina, Inc. | Biological sample temperature control system and method |
WO2010048337A2 (en) | 2008-10-22 | 2010-04-29 | Illumina, Inc. | Preservation of information related to genomic dna methylation |
WO2010051318A2 (en) * | 2008-10-31 | 2010-05-06 | Abbott Laboratories | Genomic classification of colorectal cancer based on patterns of gene copy number alterations |
JP5391279B2 (ja) * | 2008-10-31 | 2014-01-15 | アッヴィ・インコーポレイテッド | 1種以上の医薬組成物の有効性を試験することに使用する癌細胞系のパネルを構築するための方法 |
US8498821B2 (en) * | 2008-10-31 | 2013-07-30 | Abbvie Inc. | Genomic classification of malignant melanoma based on patterns of gene copy number alterations |
JP5632382B2 (ja) * | 2008-10-31 | 2014-11-26 | アッヴィ・インコーポレイテッド | 遺伝子コピー数変化のパターンに基づいた非小細胞肺癌のゲノム分類 |
PT3130923T (pt) | 2008-11-14 | 2020-06-17 | Brigham & Womens Hospital Inc | Métodos terapêuticos relacionados com células estaminais |
US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
WO2010065617A1 (en) | 2008-12-02 | 2010-06-10 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
CN102439454B (zh) | 2009-02-11 | 2015-05-13 | 卡里斯Mpi公司 | 肿瘤的分子谱分析 |
US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
CN102448977A (zh) * | 2009-04-09 | 2012-05-09 | 加州理工学院 | 用于聚合物合成的多路复用位点 |
WO2010124372A1 (en) | 2009-04-29 | 2010-11-04 | Genomedx Biosciences, Inc. | Systems and methods for expression-based classification of thyroid tissue |
WO2010129934A2 (en) | 2009-05-07 | 2010-11-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
US20120190574A1 (en) | 2009-06-19 | 2012-07-26 | The Arizona Board of Regents, A body Corporate of the State of Arizona for and on behalf of Arizona | Compound Arrays for Sample Profiling |
WO2010151807A1 (en) | 2009-06-26 | 2010-12-29 | Sirigen, Inc. | Signal amplified biological detection with conjugated polymers |
WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
WO2011022502A1 (en) | 2009-08-18 | 2011-02-24 | Georgetown University | Boronic acid compositions and methods related to cancer |
US20110059453A1 (en) * | 2009-08-23 | 2011-03-10 | Affymetrix, Inc. | Poly(A) Tail Length Measurement by PCR |
WO2011026136A1 (en) * | 2009-08-31 | 2011-03-03 | Life Technologies Corporation | Low-volume sequencing system and method of use |
US8815779B2 (en) | 2009-09-16 | 2014-08-26 | SwitchGear Genomics, Inc. | Transcription biomarkers of biological responses and methods |
US20110081293A1 (en) | 2009-10-07 | 2011-04-07 | Sanford-Burnham Medical Research Institute | Methods and compositions related to clot-binding lipid compounds |
DK2488873T3 (en) | 2009-10-16 | 2015-11-09 | Novartis Ag | Biomarkers for pharmacodynamic tumor responses |
EP2494077A4 (en) | 2009-10-27 | 2013-08-21 | Caris Mpi Inc | MOLECULAR PROFILING FOR PERSONALIZED MEDICINE |
US20120282276A1 (en) | 2009-11-05 | 2012-11-08 | The Regents Of The University Of Michigan | Biomarkers predictive of progression of fibrosis |
EP2501414B1 (en) | 2009-11-17 | 2018-01-10 | The Trustees Of The University Of Pennsylvania | Smndelta7 degron: novel compositions and methods of use |
US9579402B2 (en) * | 2009-12-04 | 2017-02-28 | Biotium, Inc. | Heterocycle-substituted xanthene dyes |
US8501122B2 (en) | 2009-12-08 | 2013-08-06 | Affymetrix, Inc. | Manufacturing and processing polymer arrays |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
US20110143966A1 (en) * | 2009-12-15 | 2011-06-16 | Affymetrix, Inc. | Surface Modifications and Methods for their Synthesis and Use |
JP2013515008A (ja) | 2009-12-18 | 2013-05-02 | サンフォード−バーナム メディカル リサーチ インスティテュート | 凝血塊結合化合物に関連する方法および組成物 |
GB0922377D0 (en) | 2009-12-22 | 2010-02-03 | Arab Gulf University The | Mutant LDL receptor |
CA2785406A1 (en) | 2009-12-23 | 2011-06-30 | Hill's Pet Nutrition, Inc. | Compositions and methods for diagnosing and treating kidney disorders in a canine |
EP4322238A3 (en) | 2010-01-19 | 2024-05-15 | Sirigen II Limited | Novel reagents for directed biomarker signal amplification |
WO2011091435A2 (en) | 2010-01-25 | 2011-07-28 | Mount Sinai School Of Medicine | Methods of treating liver disease |
DK2531880T3 (da) | 2010-02-01 | 2016-11-07 | Illumina Inc | Fokuseringsmetoder og optiske systemer samt anordninger dermed |
CA2789125A1 (en) | 2010-02-10 | 2011-08-18 | Novartis Ag | Methods and compounds for muscle growth |
CN202281746U (zh) | 2010-03-06 | 2012-06-20 | 伊鲁米那股份有限公司 | 检测来自样品光信号的测定设备及其光学组件和光学系统 |
EA201890869A3 (ru) | 2010-06-03 | 2019-03-29 | Фармасайкликс, Инк. | Применение ингибиторов тирозинкиназы брутона (btk) |
JP2013529089A (ja) | 2010-06-07 | 2013-07-18 | エフ.ホフマン−ラ ロシュ アーゲー | インターロイキン−6受容体を阻害するモノクローナル抗体による薬剤治療に対する応答を予測するための遺伝子発現マーカー |
WO2011159942A1 (en) | 2010-06-18 | 2011-12-22 | Illumina, Inc. | Conformational probes and methods for sequencing nucleic acids |
US8759038B2 (en) | 2010-09-29 | 2014-06-24 | Illumina Cambridge Limited | Compositions and methods for sequencing nucleic acids |
EP2633069B1 (en) | 2010-10-26 | 2015-07-01 | Illumina, Inc. | Sequencing methods |
CA2819230A1 (en) | 2010-10-28 | 2012-05-03 | Yale University | Methods and compositions for assessing and treating cancer |
US9574173B2 (en) | 2010-11-15 | 2017-02-21 | Accelerated Biosciences Corp. | Generation of neural stem cells from human trophoblast stem cells |
EP2643470B1 (en) | 2010-11-24 | 2016-02-03 | Yale University | Compositions and methods for treating ischemic injury with d-dt |
JP5754685B2 (ja) * | 2010-12-02 | 2015-07-29 | 国立研究開発法人農業・食品産業技術総合研究機構 | 基板上でビルドアップ型コンビナトリアルライブラリーを合成する方法 |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
US8951781B2 (en) | 2011-01-10 | 2015-02-10 | Illumina, Inc. | Systems, methods, and apparatuses to image a sample for biological or chemical analysis |
RU2564122C2 (ru) | 2011-02-24 | 2015-09-27 | Хилл'С Пет Ньютришн, Инк. | Способ и набор для диагностики гломерулонефрита у кошки |
CN107273712B (zh) | 2011-03-02 | 2021-12-03 | 博格有限责任公司 | 基于细胞的探询式分析及其应用 |
WO2012125828A2 (en) | 2011-03-15 | 2012-09-20 | The University Of North Carolina At Chapell Hill | Methods of treating breast cancer with anthracycline therapy |
ES2731653T3 (es) | 2011-03-18 | 2019-11-18 | Eisai R&D Man Co Ltd | Métodos y usos para predecir la respuesta a la eribulina |
US20140323392A1 (en) | 2011-03-28 | 2014-10-30 | University Of Utah Research Foundation | Methods and compositions related to inhibition of viral entry |
US9777332B2 (en) | 2011-03-31 | 2017-10-03 | St. Jude Children's Research Hospital | Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia |
EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
AU2012240246A1 (en) | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
EP3150750B1 (en) | 2011-04-08 | 2018-12-26 | Prognosys Biosciences, Inc. | Peptide constructs and assay systems |
WO2012154594A1 (en) * | 2011-05-09 | 2012-11-15 | Neal Woodbury | Methods for performing patterned chemistry |
EP2718465B1 (en) | 2011-06-09 | 2022-04-13 | Illumina, Inc. | Method of making an analyte array |
CN103597097B (zh) | 2011-06-15 | 2016-08-17 | 希尔氏宠物营养品公司 | 用于诊断和监测猫科动物的甲状腺功能亢进的组合物和方法 |
WO2013009705A2 (en) | 2011-07-09 | 2013-01-17 | The Trustees Of Columbia University In The City Of New York | Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism |
WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
WO2013063519A1 (en) | 2011-10-26 | 2013-05-02 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
US20130142728A1 (en) | 2011-10-27 | 2013-06-06 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
CA3003082C (en) | 2011-10-28 | 2020-12-15 | Illumina, Inc. | Microarray fabrication system and method |
IN2014CN03463A (ja) | 2011-11-18 | 2015-10-09 | Alnylam Pharmaceuticals Inc | |
AU2012346861A1 (en) | 2011-11-30 | 2014-06-19 | AbbVie Deutschland GmbH & Co. KG | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor |
CA2858581A1 (en) | 2011-12-13 | 2013-06-20 | Genomedx Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
EP3418397B1 (en) | 2012-01-24 | 2020-10-07 | CD Diagnostics, Inc. | System for detecting infection in synovial fluid |
US10202628B2 (en) | 2012-02-17 | 2019-02-12 | President And Fellows Of Harvard College | Assembly of nucleic acid sequences in emulsions |
CA3084919A1 (en) | 2012-02-22 | 2013-08-29 | The Trustees Of The University Of Pennsylvania | Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer |
WO2013130512A2 (en) | 2012-02-27 | 2013-09-06 | The University Of North Carolina At Chapel Hill | Methods and uses for molecular tags |
CA2865575C (en) | 2012-02-27 | 2024-01-16 | Cellular Research, Inc. | Compositions and kits for molecular counting |
EP2834366B1 (en) | 2012-04-02 | 2024-05-29 | BPGbio, Inc. | Interrogatory cell-based assays and uses thereof |
US20140018253A1 (en) | 2012-04-05 | 2014-01-16 | Oregon Health And Science University | Gene expression panel for breast cancer prognosis |
CA2872177A1 (en) | 2012-05-08 | 2013-11-14 | Quidel Corporation | Device for isolating an analyte from a sample, and methods of use |
WO2013177245A2 (en) | 2012-05-22 | 2013-11-28 | Nanostring Technologies, Inc. | Nano46 genes and methods to predict breast cancer outcome |
US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
WO2014018567A1 (en) | 2012-07-24 | 2014-01-30 | Pharmacyclics, Inc. | Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk) |
WO2014025761A1 (en) | 2012-08-07 | 2014-02-13 | Children's Medical Center Corporation | Methods to treat neurodegenerative diseases |
WO2014028884A2 (en) | 2012-08-16 | 2014-02-20 | Genomedx Biosciences, Inc. | Cancer diagnostics using biomarkers |
US10895534B2 (en) | 2012-08-20 | 2021-01-19 | Illumina, Inc. | Method and system for fluorescence lifetime based sequencing |
WO2014031786A1 (en) | 2012-08-23 | 2014-02-27 | Northwestern University | Device with controlled fluid dynamics, for isolation of an analyte from a sample |
WO2014055117A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
CN105102611B (zh) | 2012-11-30 | 2021-09-10 | 艾克塞利瑞提德生物技术公司 | 通过调节mir-124分化干细胞的方法 |
HUE035887T2 (en) | 2012-12-05 | 2018-05-28 | Alnylam Pharmaceuticals Inc | PCSK9 iRNA preparations and methods for their use |
JP2016506720A (ja) | 2013-01-21 | 2016-03-07 | アッヴィ・インコーポレイテッド | 炎症性疾患のための抗tnf及び抗il17併用治療薬バイオマーカー |
US9411930B2 (en) | 2013-02-01 | 2016-08-09 | The Regents Of The University Of California | Methods for genome assembly and haplotype phasing |
US10089437B2 (en) | 2013-02-01 | 2018-10-02 | The Regents Of The University Of California | Methods for genome assembly and haplotype phasing |
CA3175634A1 (en) | 2013-02-28 | 2014-09-04 | Caprion Proteomics Inc. | Tuberculosis biomarkers and uses thereof |
PE20211393A1 (es) | 2013-03-14 | 2021-07-27 | Alnylam Pharmaceuticals Inc | COMPOSICIONES DE ARNi CONTRA EL COMPONENTE C5 DEL COMPLEMENTO Y METODOS PARA SU USO |
DK2970356T3 (en) | 2013-03-15 | 2018-08-27 | Illumina Cambridge Ltd | Modified nucleosides or nucleotides |
WO2014145123A2 (en) | 2013-03-15 | 2014-09-18 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State Unversity | Peptide array quality control |
US9970932B2 (en) | 2013-03-15 | 2018-05-15 | Arizona Board Of Regents On Behalf Of Arizona State University | Non-covalent patterned chemical features and use thereof in MALDI-based quality control |
US10119134B2 (en) | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
ES2935257T3 (es) | 2013-03-15 | 2023-03-03 | Univ Chicago | Métodos y composiciones relacionadas con la actividad de las células T |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
EP3633048B1 (en) | 2013-03-27 | 2022-10-12 | Alan Handyside | Assessment of risk of aneuploidy |
EP2994750B1 (en) | 2013-05-07 | 2020-08-12 | PerkinElmer Health Sciences, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
IL285780B (en) | 2013-05-22 | 2022-07-01 | Alnylam Pharmaceuticals Inc | Preparations of tmprss6 irna and methods of using them |
DK2999785T3 (en) | 2013-05-22 | 2018-07-23 | Alnylam Pharmaceuticals Inc | SERPINA1-IRNA COMPOSITIONS AND PROCEDURES FOR USE THEREOF |
PT3017065T (pt) | 2013-07-01 | 2018-12-18 | Illumina Inc | Funcionalização de superfícies sem catalisador e enxerto de polímeros |
GB2533173A (en) | 2013-08-05 | 2016-06-15 | Twist Bioscience Corp | De Novo synthesized gene libraries |
CN105659085B (zh) | 2013-08-28 | 2018-12-07 | 中美冠科生物技术(太仓)有限公司 | 预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法 |
CN105705659B (zh) | 2013-08-28 | 2019-11-29 | 贝克顿迪金森公司 | 大规模平行单细胞分析 |
JP2016537010A (ja) | 2013-09-09 | 2016-12-01 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット |
TW201610151A (zh) | 2013-09-23 | 2016-03-16 | 阿尼拉製藥公司 | 治療或預防與甲狀腺素運載蛋白相關疾病之方法 |
EP3543353A1 (en) | 2013-09-23 | 2019-09-25 | The University of Chicago | Methods and compositions relating to cancer therapy with dna damaging agents |
US9352315B2 (en) | 2013-09-27 | 2016-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method to produce chemical pattern in micro-fluidic structure |
CN105555297A (zh) | 2013-10-02 | 2016-05-04 | 小利兰斯坦福大学托管委员会 | Wnt组合物及纯化方法 |
EP3066215B1 (en) | 2013-11-06 | 2019-04-24 | The United States of America, represented by the Secretary, Department of Health and Human Services | Method for subtyping lymphoma types by means of expression profiling |
WO2015089368A2 (en) | 2013-12-12 | 2015-06-18 | Alnylam Pharmaceuticals, Inc. | Complement component irna compositions and methods of use thereof |
CA3171807A1 (en) | 2013-12-19 | 2015-06-25 | Illumina, Inc. | Substrates comprising nano-patterning surfaces and methods of preparing thereof |
US10364469B2 (en) | 2014-01-16 | 2019-07-30 | Illumina, Inc | Gene expression panel for prognosis of prostate cancer recurrence |
EP3119910A4 (en) | 2014-03-20 | 2018-02-21 | Pharmacyclics LLC | Phospholipase c gamma 2 and resistance associated mutations |
EP3149209B1 (en) | 2014-05-30 | 2021-02-17 | Genecentric Therapeutics, Inc. | Methods for typing of lung cancer |
US20160000936A1 (en) | 2014-06-10 | 2016-01-07 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
EP4219710A3 (en) | 2014-08-01 | 2023-08-16 | Dovetail Genomics, LLC | Tagging nucleic acids for sequence assembly |
GB201414098D0 (en) | 2014-08-08 | 2014-09-24 | Illumina Cambridge Ltd | Modified nucleotide linkers |
US9982250B2 (en) | 2014-08-21 | 2018-05-29 | Illumina Cambridge Limited | Reversible surface functionalization |
EP3191591A1 (en) | 2014-09-12 | 2017-07-19 | Alnylam Pharmaceuticals, Inc. | Polynucleotide agents targeting complement component c5 and methods of use thereof |
JP6672310B2 (ja) | 2014-09-15 | 2020-03-25 | アブビトロ, エルエルシー | ハイスループットヌクレオチドライブラリーシークエンシング |
US10040048B1 (en) | 2014-09-25 | 2018-08-07 | Synthego Corporation | Automated modular system and method for production of biopolymers |
JOP20200115A1 (ar) | 2014-10-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | تركيبات وطرق لتثبيط التعبير الجيني عن hao1 (حمض أوكسيداز هيدروكسيلي 1 (أوكسيداز جليكولات)) |
WO2016061487A1 (en) | 2014-10-17 | 2016-04-21 | Alnylam Pharmaceuticals, Inc. | Polynucleotide agents targeting aminolevulinic acid synthase-1 (alas1) and uses thereof |
EP3212794B1 (en) | 2014-10-30 | 2021-04-07 | Genzyme Corporation | Polynucleotide agents targeting serpinc1 (at3) and methods of use thereof |
SG11201703386XA (en) | 2014-10-31 | 2017-05-30 | Illumina Cambridge Ltd | Novel polymers and dna copolymer coatings |
US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
EP3023792A1 (en) | 2014-11-18 | 2016-05-25 | Biosims Technologies | Spot control |
CA2968065C (en) | 2014-11-26 | 2024-04-09 | Jau-Nan Lee | Induced hepatocytes and uses thereof |
US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
CA2975855A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Compositions and methods for synthetic gene assembly |
US10801065B2 (en) | 2015-02-10 | 2020-10-13 | Dana-Farber Cancer Institute, Inc. | Methods of determining levels of exposure to radiation and uses thereof |
JP2018510621A (ja) | 2015-02-13 | 2018-04-19 | アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. | パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用方法 |
WO2016134034A1 (en) | 2015-02-17 | 2016-08-25 | Dovetail Genomics Llc | Nucleic acid sequence assembly |
US9708647B2 (en) | 2015-03-23 | 2017-07-18 | Insilixa, Inc. | Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays |
AU2016235288B2 (en) | 2015-03-24 | 2019-02-28 | Illumina Cambridge Limited | Methods, carrier assemblies, and systems for imaging samples for biological or chemical analysis |
GB2554572B (en) | 2015-03-26 | 2021-06-23 | Dovetail Genomics Llc | Physical linkage preservation in DNA storage |
CA2983351C (en) | 2015-04-20 | 2024-06-04 | F. Hoffmann-La Roche Ag | Specific peptide binders to proteins identified via systemic discovery, maturation and extension process |
US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
CA2984589A1 (en) | 2015-05-01 | 2016-11-10 | The University Of British Columbia | Biomarkers for the detection of acute rejection in heart transplantation |
DK3302804T3 (da) | 2015-05-29 | 2022-09-26 | Illumina Inc | Prøveholder og analysesystem til udførelse af specifikke reaktioner |
US9752473B1 (en) | 2015-06-03 | 2017-09-05 | Valvomax, Inc. | Oil drain valve with check ball and detachable bayonet-style actuator |
EP3307316A1 (en) | 2015-06-12 | 2018-04-18 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions and methods of use thereof |
WO2016205323A1 (en) | 2015-06-18 | 2016-12-22 | Alnylam Pharmaceuticals, Inc. | Polynucleotde agents targeting hydroxyacid oxidase (glycolate oxidase, hao1) and methods of use thereof |
US10494632B2 (en) | 2015-07-10 | 2019-12-03 | Alnylam Pharmaceuticals, Inc. | Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof |
CN107835857A (zh) | 2015-07-17 | 2018-03-23 | 亿明达股份有限公司 | 用于测序应用的聚合物片层 |
US10066229B2 (en) | 2015-07-28 | 2018-09-04 | Otonomy, Inc. | Treatment using truncated Trk B and Trk C antagonists |
CA2994416A1 (en) | 2015-08-04 | 2017-02-09 | Cd Diagnostics, Inc. | Methods for detecting adverse local tissue reaction (altr) necrosis |
US10976334B2 (en) | 2015-08-24 | 2021-04-13 | Illumina, Inc. | In-line pressure accumulator and flow-control system for biological or chemical assays |
KR20180051550A (ko) | 2015-09-02 | 2018-05-16 | 알닐람 파마슈티칼스 인코포레이티드 | 프로그램된 세포사 1 리간드 1 (PD-L1) iRNA 조성물 및 그의 사용 방법 |
US9499861B1 (en) | 2015-09-10 | 2016-11-22 | Insilixa, Inc. | Methods and systems for multiplex quantitative nucleic acid amplification |
US10758886B2 (en) | 2015-09-14 | 2020-09-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Conditioned surfaces for in situ molecular array synthesis |
KR20180050411A (ko) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | 올리고핵산 변이체 라이브러리 및 그의 합성 |
CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
CN108291257B (zh) | 2015-09-24 | 2023-12-29 | 阿布维特罗有限责任公司 | 亲和-寡核苷酸缀合物及其用途 |
AU2016326734B2 (en) | 2015-09-25 | 2022-07-07 | Abvitro Llc | High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences |
US10746734B2 (en) * | 2015-10-07 | 2020-08-18 | Selma Diagnostics Aps | Flow system and methods for digital counting |
AU2016341845B2 (en) | 2015-10-18 | 2022-11-17 | Affymetrix, Inc. | Multiallelic genotyping of single nucleotide polymorphisms and indels |
WO2017070123A1 (en) | 2015-10-19 | 2017-04-27 | Dovetail Genomics, Llc | Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection |
CN115920796A (zh) | 2015-12-01 | 2023-04-07 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
CA3014911A1 (en) | 2016-02-23 | 2017-08-31 | Dovetail Genomics, Llc | Generation of phased read-sets for genome assembly and haplotype phasing |
WO2017155858A1 (en) | 2016-03-07 | 2017-09-14 | Insilixa, Inc. | Nucleic acid sequence identification using solid-phase cyclic single base extension |
EP3433262A4 (en) | 2016-03-25 | 2019-11-20 | Muralidhar Reddy Moola | COMBINATORY SYNTHESIS AND DEVELOPMENT OF BIOMARKERS |
CN116509869A (zh) | 2016-04-04 | 2023-08-01 | 希诺皮亚生物科学公司 | 使用曲匹地尔治疗锥体外系综合征 |
MA45295A (fr) | 2016-04-19 | 2019-02-27 | Alnylam Pharmaceuticals Inc | Composition d'arni de protéine de liaison de lipoprotéines haute densité (hdlbp/vigiline) et procédés pour les utiliser |
US11725248B2 (en) | 2016-04-20 | 2023-08-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Evaluation of mantle cell lymphoma and methods related thereto |
CA3023990A1 (en) | 2016-05-13 | 2017-11-16 | Dovetail Genomics Llc | Recovering long-range linkage information from preserved samples |
JP7241353B2 (ja) | 2016-05-17 | 2023-03-17 | ジーンセントリック セラピューティクス, インコーポレイテッド | 肺腺癌のサブタイピングのための方法 |
US11041214B2 (en) | 2016-05-17 | 2021-06-22 | Genecentric Therapeutics, Inc. | Methods for subtyping of lung squamous cell carcinoma |
US10900076B2 (en) | 2016-05-18 | 2021-01-26 | Illumina, Inc. | Self assembled patterning using patterned hydrophobic surfaces |
WO2017214518A1 (en) | 2016-06-10 | 2017-12-14 | Alnylam Pharmaceuticals, Inc. | COMPLETMENT COMPONENT C5 iRNA COMPOSTIONS AND METHODS OF USE THEREOF FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
EP3472181A4 (en) | 2016-06-20 | 2020-05-13 | Healthtell Inc. | METHOD FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES |
KR20190020106A (ko) | 2016-06-20 | 2019-02-27 | 헬스텔 인크. | 자가면역 질환의 차별적 진단 방법 |
EP3260552A1 (en) | 2016-06-20 | 2017-12-27 | Istituto Europeo di Oncologia (IEO) | Methods and kits comprising gene signatures for stratifying breast cancer patients |
WO2018013883A1 (en) | 2016-07-14 | 2018-01-18 | Caprion Proteomics Inc. | Biomarkers of latent tuberculosis infection |
WO2018025242A2 (en) | 2016-08-04 | 2018-02-08 | Baylor Research Institute | Methods for diagnosing and treating esophageal cancer |
SG11201901563UA (en) | 2016-08-22 | 2019-03-28 | Twist Bioscience Corp | De novo synthesized nucleic acid libraries |
EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
US11713486B2 (en) | 2016-09-15 | 2023-08-01 | The Regents Of The University Of California | Biomarkers for bipolar disorder and schizophrenia |
EP3516528A4 (en) | 2016-09-21 | 2020-06-24 | Twist Bioscience Corporation | NUCLEIC ACID BASED DATA STORAGE |
JP6929354B2 (ja) | 2016-09-24 | 2021-09-01 | アブビトロ, エルエルシー | 親和性−オリゴヌクレオチドコンジュゲートおよびその使用 |
WO2018064116A1 (en) | 2016-09-28 | 2018-04-05 | Illumina, Inc. | Methods and systems for data compression |
CA3043264A1 (en) | 2016-11-11 | 2018-05-17 | Healthtell Inc. | Methods for identifying candidate biomarkers |
WO2018098241A1 (en) | 2016-11-22 | 2018-05-31 | University Of Rochester | Methods of assessing risk of recurrent prostate cancer |
TWI788312B (zh) | 2016-11-23 | 2023-01-01 | 美商阿尼拉製藥公司 | 絲胺酸蛋白酶抑制因子A1 iRNA組成物及其使用方法 |
KR102514213B1 (ko) | 2016-12-16 | 2023-03-27 | 트위스트 바이오사이언스 코포레이션 | 면역 시냅스의 변이체 라이브러리 및 그의 합성 |
TW202317151A (zh) | 2016-12-16 | 2023-05-01 | 美商阿尼拉製藥公司 | 使用甲狀腺素運載蛋白(TTR)iRNA組成物於治療或預防TTR相關疾病之方法 |
US11208697B2 (en) | 2017-01-20 | 2021-12-28 | Decipher Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
JP2020508661A (ja) | 2017-02-22 | 2020-03-26 | ツイスト バイオサイエンス コーポレーション | 核酸ベースのデータ保存 |
CA3055925A1 (en) | 2017-03-09 | 2018-09-13 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
WO2018165532A1 (en) | 2017-03-10 | 2018-09-13 | Baylor Research Institute | Methods for diagnosing and treating gastric cancer using mirna expression |
CN110913865A (zh) | 2017-03-15 | 2020-03-24 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
US10729741B2 (en) | 2017-03-27 | 2020-08-04 | Neomatrix Therapeutics Inc. | Methods of treating burns with i.v. cP12 in a window from 2 to 6 hours after injury |
JP7113842B2 (ja) | 2017-03-29 | 2022-08-05 | クラウン バイオサイエンス,インコーポレイテッド(タイツァン) | 胃がんのセツキシマブ感受性を決定するためのシステムおよび方法 |
AU2018254437A1 (en) | 2017-04-18 | 2019-11-28 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis B virus (HBV) infection |
WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
US11484543B2 (en) | 2017-05-18 | 2022-11-01 | The Rockefeller University | Compositions and methods for diagnosing and treating diseases and disorders associated with mutant KCNJ5 |
WO2018213803A1 (en) | 2017-05-19 | 2018-11-22 | Neon Therapeutics, Inc. | Immunogenic neoantigen identification |
CN110914448A (zh) | 2017-06-02 | 2020-03-24 | 昂飞股份有限公司 | 使用差异性标记的等位基因特异性探针分析混合样品的基于阵列的方法 |
WO2018223057A1 (en) | 2017-06-02 | 2018-12-06 | Affymetrix, Inc. | Array-based methods for analysing mixed samples using different allele-specific labels, in particular for detection of fetal aneuploidies |
WO2018223053A1 (en) | 2017-06-02 | 2018-12-06 | Affymetrix, Inc. | Array-based methods for analysing mixed samples using differently labelled allele-specific probes |
US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
EP3638814B8 (en) | 2017-06-14 | 2023-06-21 | The United States of America, as Represented by The Secretary, Department of Health and Human Services | Method for determining lymphoma type |
EP3655418A4 (en) | 2017-06-22 | 2021-05-19 | Triact Therapeutics, Inc. | METHOD OF TREATMENT OF GLIOBLASTOMA |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
WO2019018764A1 (en) | 2017-07-21 | 2019-01-24 | Genecentric Therapeutics, Inc. | METHODS OF DETERMINING RESPONSE TO PARP INHIBITORS |
WO2019032525A1 (en) | 2017-08-07 | 2019-02-14 | Genecentric Therapeutics, Inc. | PROCESS FOR SUBTYPING EPIDERMOID CARCINOMA OF HEAD AND NECK |
SG11202002194UA (en) | 2017-09-11 | 2020-04-29 | Twist Bioscience Corp | Gpcr binding proteins and synthesis thereof |
WO2019055618A1 (en) | 2017-09-15 | 2019-03-21 | Arizona Board Of Regents On Behalf Of Arizona State University | METHODS OF CLASSIFYING RESPONSES TO ANTICANCER IMMUNOTHERAPY |
US11628144B2 (en) | 2017-09-29 | 2023-04-18 | Triact Therapeutics, Inc. | Iniparib formulations and uses thereof |
CA3079613A1 (en) | 2017-10-20 | 2019-04-25 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
US11709164B2 (en) | 2017-10-26 | 2023-07-25 | National University Of Singapore | Approach for universal monitoring of minimal residual disease in acute myeloid leukemia |
WO2019084351A1 (en) | 2017-10-27 | 2019-05-02 | The Regents Of The University Of California | SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS |
CA3078971A1 (en) | 2017-11-01 | 2019-05-09 | Alnylam Pharmaceuticals, Inc. | Complement component c3 irna compositions and methods of use thereof |
US20200385719A1 (en) | 2017-11-16 | 2020-12-10 | Alnylam Pharmaceuticals, Inc. | Kisspeptin 1 (kiss1) irna compositions and methods of use thereof |
WO2019100039A1 (en) | 2017-11-20 | 2019-05-23 | Alnylam Pharmaceuticals, Inc. | Serum amyloid p component (apcs) irna compositions and methods of use thereof |
AR113490A1 (es) | 2017-12-12 | 2020-05-06 | Amgen Inc | CONSTRUCCIONES DE ARNi PARA INHIBIR LA EXPRESIÓN DE PNPLA3 Y MÉTODOS DE USO DE LAS MISMAS |
US20200308588A1 (en) | 2017-12-18 | 2020-10-01 | Alnylam Pharmaceuticals, Inc. | High mobility group box-1 (hmgb1) irna compositions and methods of use thereof |
CN112041438A (zh) | 2018-01-04 | 2020-12-04 | 特韦斯特生物科学公司 | 基于dna的数字信息存储 |
TW202016304A (zh) | 2018-05-14 | 2020-05-01 | 美商阿尼拉製藥公司 | 血管收縮素原(AGT)iRNA組成物及其使用方法 |
EP3814497A4 (en) | 2018-05-18 | 2022-03-02 | Twist Bioscience Corporation | POLYNUCLEOTIDES, REAGENTS, AND METHODS FOR NUCLEIC ACID HYBRIDIZATION |
EP3827094A1 (en) | 2018-07-24 | 2021-06-02 | Affymetrix, Inc. | Array based method and kit for determining copy number and genotype in pseudogenes |
TW202023574A (zh) | 2018-08-13 | 2020-07-01 | 美商阿尼拉製藥公司 | B型肝炎病毒(HBV)dsRNA劑組合物及其使用方法 |
JP6958518B2 (ja) * | 2018-09-07 | 2021-11-02 | 株式会社明電舎 | 動力計制御装置 |
CN112424355A (zh) | 2018-09-18 | 2021-02-26 | 阿尔尼拉姆医药品有限公司 | 己酮糖激酶(KHK)iRNA组合物及其使用方法 |
TW202028465A (zh) | 2018-09-28 | 2020-08-01 | 美商阿尼拉製藥公司 | 甲狀腺素運載蛋白(TTR)iRNA組成物及其治療或預防TTR相關眼部疾病之使用方法 |
CA3115922A1 (en) | 2018-10-09 | 2020-04-16 | Genecentric Therapeutics, Inc. | Detecting cancer cell of origin |
WO2020104482A1 (en) | 2018-11-20 | 2020-05-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma |
AU2019389175A1 (en) | 2018-11-30 | 2021-06-10 | Caris Mpi, Inc. | Next-generation molecular profiling |
MX2021006784A (es) | 2018-12-10 | 2021-07-15 | Amgen Inc | Constructos de arni para inhibir la expresion de pnpla3 y metodos de uso de estos. |
JP2022515744A (ja) | 2018-12-20 | 2022-02-22 | プラクシス プレシジョン メディシンズ, インコーポレイテッド | Kcnt1関連障害の治療のための組成物及び方法 |
US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
WO2020160450A1 (en) | 2019-02-01 | 2020-08-06 | Health Research, Inc. | Methods and compositions for treating resistant and recurrent forms of cancer |
JP2022522668A (ja) | 2019-02-26 | 2022-04-20 | ツイスト バイオサイエンス コーポレーション | 抗体を最適化するための変異体核酸ライブラリ |
CN113766930A (zh) | 2019-02-26 | 2021-12-07 | 特韦斯特生物科学公司 | Glp1受体的变异核酸文库 |
JP2022525322A (ja) | 2019-03-14 | 2022-05-12 | インシリクサ, インコーポレイテッド | 時間ゲート蛍光ベースの検出のための方法およびシステム |
US11421271B2 (en) | 2019-03-28 | 2022-08-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing using photoswitchable labels |
CN114051537A (zh) | 2019-04-17 | 2022-02-15 | 艾基诺米公司 | 用于早期诊断子宫平滑肌瘤和平滑肌肉瘤的改进方法 |
US20220307022A1 (en) | 2019-05-30 | 2022-09-29 | Amgen Inc. | Rnai constructs for inhibiting scap expression and methods of use thereof |
JP2022550497A (ja) | 2019-06-21 | 2022-12-02 | ツイスト バイオサイエンス コーポレーション | バーコードに基づいた核酸配列アセンブリ |
EP4007812A1 (en) | 2019-08-01 | 2022-06-08 | Alnylam Pharmaceuticals, Inc. | Serpin family f member 2 (serpinf2) irna compositions and methods of use thereof |
EP4007811A2 (en) | 2019-08-01 | 2022-06-08 | Alnylam Pharmaceuticals, Inc. | Carboxypeptidase b2 (cpb2) irna compositions and methods of use thereof |
WO2021030522A1 (en) | 2019-08-13 | 2021-02-18 | Alnylam Pharmaceuticals, Inc. | SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF |
MX2022001864A (es) | 2019-08-13 | 2022-05-30 | Amgen Inc | Construcciones de arni para inhibir la expresión de slc30a8 y métodos de uso de las mismas. |
WO2021067550A1 (en) | 2019-10-02 | 2021-04-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
WO2021076828A1 (en) | 2019-10-18 | 2021-04-22 | Alnylam Pharmaceuticals, Inc. | Solute carrier family member irna compositions and methods of use thereof |
EP4048793A1 (en) | 2019-10-22 | 2022-08-31 | Alnylam Pharmaceuticals, Inc. | Complement component c3 irna compositions and methods of use thereof |
EP4051795A1 (en) | 2019-11-01 | 2022-09-07 | Alnylam Pharmaceuticals, Inc. | Huntingtin (htt) irna agent compositions and methods of use thereof |
WO2021092145A1 (en) | 2019-11-06 | 2021-05-14 | Alnylam Pharmaceuticals, Inc. | Transthyretin (ttr) irna composition and methods of use thereof for treating or preventing ttr-associated ocular diseases |
WO2021102373A1 (en) | 2019-11-22 | 2021-05-27 | Alnylam Pharmaceuticals, Inc. | Ataxin3 (atxn3) rnai agent compositions and methods of use thereof |
CA3163319A1 (en) | 2019-12-02 | 2021-06-10 | Caris Mpi, Inc. | Pan-cancer platinum response predictor |
IL293824A (en) | 2019-12-13 | 2022-08-01 | Alnylam Pharmaceuticals Inc | Compositions of RNA material (c9orf72) human chromosome 9 open reading frame 72 and methods of using them |
WO2021126734A1 (en) | 2019-12-16 | 2021-06-24 | Alnylam Pharmaceuticals, Inc. | Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof |
WO2021154941A1 (en) | 2020-01-31 | 2021-08-05 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions for use in the treatment of amyotrophic lateral sclerosis (als) |
CA3171654A1 (en) | 2020-02-18 | 2021-08-26 | Alnylam Pharmaceuticals, Inc. | Apolipoprotein c3 (apoc3) irna compositions and methods of use thereof |
EP4114947A1 (en) | 2020-03-05 | 2023-01-11 | Alnylam Pharmaceuticals, Inc. | Complement component c3 irna compositions and methods of use thereof for treating or preventing complement component c3-associated diseases |
KR20220150380A (ko) | 2020-03-06 | 2022-11-10 | 알닐람 파마슈티칼스 인코포레이티드 | 케토헥소키나제 (KHK) iRNA 조성물 및 이의 사용 방법 |
WO2021188611A1 (en) | 2020-03-18 | 2021-09-23 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for treating subjects having a heterozygous alanine-glyoxylate aminotransferase gene (agxt) variant |
EP4127168A1 (en) | 2020-03-26 | 2023-02-08 | Alnylam Pharmaceuticals, Inc. | Coronavirus irna compositions and methods of use thereof |
WO2021206922A1 (en) | 2020-04-07 | 2021-10-14 | Alnylam Pharmaceuticals, Inc. | Transmembrane serine protease 2 (tmprss2) irna compositions and methods of use thereof |
EP4133076A1 (en) | 2020-04-07 | 2023-02-15 | Alnylam Pharmaceuticals, Inc. | Angiotensin-converting enzyme 2 (ace2) irna compositions and methods of use thereof |
KR20230018377A (ko) | 2020-04-27 | 2023-02-07 | 알닐람 파마슈티칼스 인코포레이티드 | 아포지질단백질 e (apoe) irna 제제 조성물 및 이의 사용 방법 |
KR20230017789A (ko) | 2020-04-30 | 2023-02-06 | 알닐람 파마슈티칼스 인코포레이티드 | 보체 인자 B (CFB) iRNA 조성물 및 이의 사용 방법 |
EP3907301A1 (en) | 2020-05-08 | 2021-11-10 | Istituto Europeo di Oncologia S.r.l. | Methods and kits for determining the risk of breast cancer recurrence |
CA3162416C (en) | 2020-05-15 | 2023-07-04 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of argininosuccinate synthetase (ass1) |
EP4150077A1 (en) | 2020-05-15 | 2023-03-22 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of transmembrane channel-like protein 1 (tmc1) |
EP4150076A1 (en) | 2020-05-15 | 2023-03-22 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of methyl-cpg binding protein 2 (mecp2) |
EP4150086A1 (en) | 2020-05-15 | 2023-03-22 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of leucine rich repeat kinase 2 (lrrk2) |
WO2021231692A1 (en) | 2020-05-15 | 2021-11-18 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of otoferlin (otof) |
WO2021231691A1 (en) | 2020-05-15 | 2021-11-18 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of retinoschisin 1 (rsi) |
EP4150078A1 (en) | 2020-05-15 | 2023-03-22 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of argininosuccinate lyase (asl) |
WO2021231679A1 (en) | 2020-05-15 | 2021-11-18 | Korro Bio, Inc. | Methods and compositions for the adar-mediated editing of gap junction protein beta 2 (gjb2) |
EP4158026A2 (en) | 2020-06-01 | 2023-04-05 | Amgen Inc. | Rnai constructs for inhibiting hsd17b13 expression and methods of use thereof |
US11408000B2 (en) | 2020-06-03 | 2022-08-09 | Triplet Therapeutics, Inc. | Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity |
EP4162050A1 (en) | 2020-06-09 | 2023-04-12 | Alnylam Pharmaceuticals, Inc. | Rnai compositions and methods of use thereof for delivery by inhalation |
BR112022024420A2 (pt) | 2020-06-18 | 2023-01-17 | Alnylam Pharmaceuticals Inc | Composições de irna de xantina desidrogenase (xdh) e métodos de uso das mesmas |
US11787831B2 (en) | 2020-06-22 | 2023-10-17 | Illumina Cambridge Limited | Nucleosides and nucleotides with 3′ acetal blocking group |
IL299771A (en) | 2020-07-10 | 2023-03-01 | Inst Nat Sante Rech Med | Methods and compounds for the treatment of epilepsy |
US11981964B2 (en) | 2020-07-28 | 2024-05-14 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
WO2022066847A1 (en) | 2020-09-24 | 2022-03-31 | Alnylam Pharmaceuticals, Inc. | Dipeptidyl peptidase 4 (dpp4) irna compositions and methods of use thereof |
WO2022076291A1 (en) | 2020-10-05 | 2022-04-14 | Alnylam Pharmaceuticals, Inc. | G protein-coupled receptor 75 (gpr75) irna compositions and methods of use thereof |
EP4229210A1 (en) | 2020-10-19 | 2023-08-23 | Twist Bioscience Corporation | Methods of synthesizing oligonucleotides using tethered nucleotides |
EP4232582A1 (en) | 2020-10-23 | 2023-08-30 | Alnylam Pharmaceuticals, Inc. | Mucin 5b (muc5b) irna compositions and methods of use thereof |
EP4244355A1 (en) | 2020-11-13 | 2023-09-20 | Alnylam Pharmaceuticals, Inc. | Coagulation factor v (f5) irna compositions and methods of use thereof |
CA3201452A1 (en) | 2020-12-01 | 2022-06-09 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression |
EP4259795A1 (en) | 2020-12-08 | 2023-10-18 | Alnylam Pharmaceuticals, Inc. | Coagulation factor x (f10) irna compositions and methods of use thereof |
US20220195517A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Long stokes shift chromenoquinoline dyes and uses in sequencing applications |
US20220195196A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Alkylpyridinium coumarin dyes and uses in sequencing applications |
US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
EP4274896A1 (en) | 2021-01-05 | 2023-11-15 | Alnylam Pharmaceuticals, Inc. | Complement component 9 (c9) irna compositions and methods of use thereof |
WO2022174000A2 (en) | 2021-02-12 | 2022-08-18 | Alnylam Pharmaceuticals, Inc. | Superoxide dismutase 1 (sod1) irna compositions and methods of use thereof for treating or preventing superoxide dismutase 1- (sod1-) associated neurodegenerative diseases |
WO2022175815A1 (en) | 2021-02-19 | 2022-08-25 | Pfizer Inc. | Methods of protecting rna |
WO2022182864A1 (en) | 2021-02-25 | 2022-09-01 | Alnylam Pharmaceuticals, Inc. | Prion protein (prnp) irna compositions and methods and methods of use thereof |
JP2024515423A (ja) | 2021-02-26 | 2024-04-10 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | ケトヘキソキナーゼ(KHK)iRNA組成物およびその使用方法 |
AU2022231003A1 (en) | 2021-03-04 | 2023-09-14 | Alnylam Pharmaceuticals, Inc. | Angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof |
EP4305169A1 (en) | 2021-03-12 | 2024-01-17 | Alnylam Pharmaceuticals, Inc. | Glycogen synthase kinase 3 alpha (gsk3a) irna compositions and methods of use thereof |
CA3214499A1 (en) | 2021-03-29 | 2022-10-06 | Alnylam Pharmaceuticals, Inc. | Huntingtin (htt) irna agent compositions and methods of use thereof |
WO2022212153A1 (en) | 2021-04-01 | 2022-10-06 | Alnylam Pharmaceuticals, Inc. | Proline dehydrogenase 2 (prodh2) irna compositions and methods of use thereof |
AU2022264478A1 (en) | 2021-04-26 | 2023-10-12 | Alnylam Pharmaceuticals, Inc. | Transmembrane protease, serine 6 (tmprss6) irna compositions and methods of use thereof |
WO2022232343A1 (en) | 2021-04-29 | 2022-11-03 | Alnylam Pharmaceuticals, Inc. | Signal transducer and activator of transcription factor 6 (stat6) irna compositions and methods of use thereof |
KR20220149828A (ko) | 2021-04-30 | 2022-11-09 | 삼성전자주식회사 | 반도체 소자 |
AU2022269804A1 (en) | 2021-05-05 | 2023-11-02 | Illumina Cambridge Limited | Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing |
EP4341401A1 (en) | 2021-05-18 | 2024-03-27 | Alnylam Pharmaceuticals, Inc. | Sodium-glucose cotransporter-2 (sglt2) irna compositions and methods of use thereof |
WO2022246023A1 (en) | 2021-05-20 | 2022-11-24 | Korro Bio, Inc. | Methods and compositions for adar-mediated editing |
WO2022243480A1 (en) | 2021-05-20 | 2022-11-24 | Illumina, Inc. | Compositions and methods for sequencing by synthesis |
WO2022256283A2 (en) | 2021-06-01 | 2022-12-08 | Korro Bio, Inc. | Methods for restoring protein function using adar |
EP4347823A1 (en) | 2021-06-02 | 2024-04-10 | Alnylam Pharmaceuticals, Inc. | Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof |
JP2024521907A (ja) | 2021-06-04 | 2024-06-04 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | ヒト9番染色体オープンリーディングフレーム72(C9ORF72)iRNA剤組成物及びその使用方法 |
AR126070A1 (es) | 2021-06-08 | 2023-09-06 | Alnylam Pharmaceuticals Inc | Composiciones y métodos para tratar o prevenir la enfermedad de stargardt y/o trastornos asociados con la proteína transportadora de retinol 4 (rbp4) |
US20230016633A1 (en) | 2021-06-15 | 2023-01-19 | Illumina, Inc. | Hydrogel-free surface functionalization for sequencing |
EP4363574A1 (en) | 2021-06-29 | 2024-05-08 | Korro Bio, Inc. | Methods and compositions for adar-mediated editing |
US20230194709A9 (en) | 2021-06-29 | 2023-06-22 | Seagate Technology Llc | Range information detection using coherent pulse sets with selected waveform characteristics |
AU2022314619A1 (en) | 2021-07-21 | 2024-01-04 | Alnylam Pharmaceuticals, Inc. | Metabolic disorder-associated target gene irna compositions and methods of use thereof |
AU2022316139A1 (en) | 2021-07-23 | 2024-01-18 | Alnylam Pharmaceuticals, Inc. | Beta-catenin (ctnnb1) irna compositions and methods of use thereof |
EP4373958A1 (en) | 2021-07-23 | 2024-05-29 | Illumina, Inc. | Methods for preparing substrate surface for dna sequencing |
WO2023009687A1 (en) | 2021-07-29 | 2023-02-02 | Alnylam Pharmaceuticals, Inc. | 3-hydroxy-3-methylglutaryl-coa reductase (hmgcr) irna compositions and methods of use thereof |
EP4381067A1 (en) | 2021-08-03 | 2024-06-12 | Alnylam Pharmaceuticals, Inc. | Transthyretin (ttr) irna compositions and methods of use thereof |
IL310295A (en) | 2021-08-04 | 2024-03-01 | Alnylam Pharmaceuticals Inc | iRNA compositions and methods for silencing angiotensinogen (AGT) |
BR112024001923A2 (pt) | 2021-08-13 | 2024-04-30 | Alnylam Pharmaceuticals Inc | Composições de irna de fator xii (f12) e métodos de usos das mesmas |
WO2023044370A2 (en) | 2021-09-17 | 2023-03-23 | Alnylam Pharmaceuticals, Inc. | Irna compositions and methods for silencing complement component 3 (c3) |
CA3232420A1 (en) | 2021-09-20 | 2023-03-23 | Alnylam Pharmaceuticals, Inc. | Inhibin subunit beta e (inhbe) modulator compositions and methods of use thereof |
IL311864A (en) | 2021-10-15 | 2024-06-01 | Alnylam Pharmaceuticals Inc | IRNA compositions for extrahepatic administration and methods of using them |
AU2022371198A1 (en) | 2021-10-20 | 2024-05-02 | Illumina, Inc. | Methods for capturing library dna for sequencing |
CA3234835A1 (en) | 2021-10-22 | 2023-04-27 | Korro Bio, Inc. | Methods and compositions for disrupting nrf2-keap1 protein interaction by adar mediated rna editing |
CA3235262A1 (en) | 2021-10-22 | 2023-04-27 | Amgen Inc. | Rnai constructs for inhibiting gpam expression and methods of use thereof |
TW202334418A (zh) | 2021-10-29 | 2023-09-01 | 美商艾拉倫製藥股份有限公司 | 杭丁頓(HTT)iRNA劑組成物及其使用方法 |
IL312399A (en) | 2021-10-29 | 2024-06-01 | Alnylam Pharmaceuticals Inc | Complement factor B (CFB) iRNA compositions and methods of using them |
WO2023122762A1 (en) | 2021-12-22 | 2023-06-29 | Camp4 Therapeutics Corporation | Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas |
WO2023122758A1 (en) | 2021-12-22 | 2023-06-29 | Cornell University | Prognostic/predictive epigenetic breast cancer signature |
WO2023122363A1 (en) | 2021-12-23 | 2023-06-29 | Illumina Software, Inc. | Dynamic graphical status summaries for nucelotide sequencing |
US20230215515A1 (en) | 2021-12-23 | 2023-07-06 | Illumina Software, Inc. | Facilitating secure execution of external workflows for genomic sequencing diagnostics |
WO2023129764A1 (en) | 2021-12-29 | 2023-07-06 | Illumina Software, Inc. | Automatically switching variant analysis model versions for genomic analysis applications |
WO2023141314A2 (en) | 2022-01-24 | 2023-07-27 | Alnylam Pharmaceuticals, Inc. | Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereof |
AU2023240337A1 (en) | 2022-03-22 | 2024-01-18 | Illumina, Inc. | Substrate with orthogonally functional nanodomains |
US20230304086A1 (en) | 2022-03-28 | 2023-09-28 | Illumina Cambridge Limited | Labeled avidin and methods for sequencing |
US20230314322A1 (en) | 2022-03-29 | 2023-10-05 | Illumina, Inc. | Systems and methods of sequencing polynucleotides |
WO2023232829A1 (en) | 2022-05-31 | 2023-12-07 | Illumina, Inc | Compositions and methods for nucleic acid sequencing |
WO2023240277A2 (en) | 2022-06-10 | 2023-12-14 | Camp4 Therapeutics Corporation | Methods of modulating progranulin expression using antisense oligonucleotides targeting regulatory rnas |
US20230416279A1 (en) | 2022-06-28 | 2023-12-28 | Illumina Cambridge Limited | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing |
WO2024039776A2 (en) | 2022-08-18 | 2024-02-22 | Alnylam Pharmaceuticals, Inc. | Universal non-targeting sirna compositions and methods of use thereof |
WO2024039516A1 (en) | 2022-08-19 | 2024-02-22 | Illumina, Inc. | Third dna base pair site-specific dna detection |
US20240140939A1 (en) | 2022-09-30 | 2024-05-02 | Illumina Cambridge Limited | Compositions and methods for reducing photo damage during sequencing |
WO2024119145A1 (en) | 2022-12-01 | 2024-06-06 | Camp4 Therapeutics Corporation | Modulation of syngap1 gene transcription using antisense oligonucleotides targeting regulatory rnas |
WO2024123748A1 (en) | 2022-12-07 | 2024-06-13 | Illumina, Inc. | Etch-free photoresist patterning in multi-depth nanowells |
Family Cites Families (137)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3281860A (en) * | 1964-11-09 | 1966-10-25 | Dick Co Ab | Ink jet nozzle |
CH508202A (fr) * | 1969-02-26 | 1971-05-31 | Micromedic Systems Inc | Mécanisme à cliquets pour entraîner un organe rotatif et utilisation de ce mécanisme |
AU470272B2 (en) * | 1972-05-02 | 1976-03-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Apparatus and process forthe production of photopolymer plates |
US4031197A (en) * | 1973-04-25 | 1977-06-21 | Gte New Ventures Corporation | In vitro method for determining allergic hypersensitivity |
US3915704A (en) * | 1973-11-01 | 1975-10-28 | Xerox Corp | Photoinduced, acid catalyzed degradation of degradable polymers |
US4166457A (en) * | 1976-08-16 | 1979-09-04 | University Of Utah Research Institute | Fluid self-sealing bioelectrode |
US4121222A (en) * | 1977-09-06 | 1978-10-17 | A. B. Dick Company | Drop counter ink replenishing system |
US4392362A (en) * | 1979-03-23 | 1983-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Micro miniature refrigerators |
US4282287A (en) * | 1980-01-24 | 1981-08-04 | Giese Roger W | Biochemical avidin-biotin multiple-layer system |
US4327073A (en) * | 1980-04-07 | 1982-04-27 | Huang Henry V | Automated method for quantitative analysis of biological fluids |
US4704256A (en) * | 1980-09-23 | 1987-11-03 | California Institute Of Technology | Apparatus for the sequential performance of chemical processes |
US4378333A (en) * | 1980-12-11 | 1983-03-29 | Laipply Thomas C | Device for preparing blood smears on glass slides and method therefor |
US4711955A (en) * | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
AR231590A1 (es) | 1981-04-29 | 1984-12-28 | Ciba Geigy Ag | Dispositivo de analisis inmunologico y procedimiento para obtenerlo |
US4483920A (en) * | 1982-05-17 | 1984-11-20 | Hahnemann University | Immobilization of message RNA directly from cells onto filter material |
DE3301833A1 (de) * | 1983-01-20 | 1984-07-26 | Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig | Verfahren zur simultanen synthese mehrerer oligonocleotide an fester phase |
US4994373A (en) * | 1983-01-27 | 1991-02-19 | Enzo Biochem, Inc. | Method and structures employing chemically-labelled polynucleotide probes |
US4591570A (en) * | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
US4584277A (en) * | 1983-04-05 | 1986-04-22 | Syntex (U.S.A.) Inc. | Fluorescent multiparameter particle analysis |
GB8314523D0 (en) * | 1983-05-25 | 1983-06-29 | Lowe C R | Diagnostic device |
US4987065A (en) * | 1983-07-05 | 1991-01-22 | Enzo Biochem, Inc. | In vivo labelling of polynucleotide sequences |
US4542102A (en) * | 1983-07-05 | 1985-09-17 | Molecular Diagnostics, Inc. | Coupling of nucleic acids to solid support by photochemical methods |
US4677054A (en) * | 1983-08-08 | 1987-06-30 | Sloan-Kettering Institute For Cancer Research | Method for simple analysis of relative nucleic acid levels in multiple small samples by cytoplasmic dot hybridization |
US4598049A (en) * | 1983-08-31 | 1986-07-01 | Systec Inc. | General purpose gene synthesizer |
JP2548112B2 (ja) * | 1983-09-02 | 1996-10-30 | シンジェン,インコーポレイテッド | 担体およびオリゴヌクレオチドの合成 |
US4746490A (en) * | 1983-09-22 | 1988-05-24 | Saneii Hossain H | Solid phase peptide synthesizer |
US4849513A (en) * | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
US4613566A (en) * | 1984-01-23 | 1986-09-23 | President And Fellows Of Harvard College | Hybridization assay and kit therefor |
JPS60155942A (ja) * | 1984-01-25 | 1985-08-16 | Fuji Photo Film Co Ltd | 液体試料点着装置 |
FI71768C (fi) * | 1984-02-17 | 1987-02-09 | Orion Yhtymae Oy | Foerbaettrade nykleinsyrareagenser och foerfarande foer deras framstaellning. |
US4668476A (en) * | 1984-03-23 | 1987-05-26 | Applied Biosystems, Inc. | Automated polypeptide synthesis apparatus |
US4704353A (en) * | 1984-04-27 | 1987-11-03 | Molecular Devices Corporation | Photoresponsive redox detection and discrimination |
EP0164206B1 (en) * | 1984-05-02 | 1988-11-02 | Brendan James Hamill | An apparatus for the chemical synthesis of oligonucleotides |
US4861420A (en) * | 1984-06-04 | 1989-08-29 | Tactile Perceptions, Inc. | Method of making a semiconductor transducer |
IL75464A (en) * | 1984-06-12 | 1990-08-31 | Orgenics Ltd | Method and apparatus for multi-analyte assay |
US4755458A (en) * | 1984-08-30 | 1988-07-05 | Enzo Biochem, Inc. | Composition and method for the detection of the presence of a polynucleotide sequence of interest |
US4586546A (en) * | 1984-10-23 | 1986-05-06 | Cetus Corporation | Liquid handling device and method |
US4820630A (en) * | 1984-11-23 | 1989-04-11 | Digene Diagnostics, Incorporated | Assay for nucleic acid sequences, particularly genetic lesions, using interactive labels |
US4670379A (en) * | 1984-12-19 | 1987-06-02 | E. I. Du Pont De Nemours And Company | Polynucleotide hydridization assays employing catalyzed luminescence |
US4607526A (en) * | 1984-12-21 | 1986-08-26 | Allied Corporation | Particle analysis system |
US5026840A (en) * | 1985-01-10 | 1991-06-25 | Molecular Diagnostics, Inc. | Photochemical nucleic acid-labeling reagent having a polyalklamine spacer |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
US4675301A (en) * | 1985-04-01 | 1987-06-23 | Eastman Kodak Company | Method for correcting for changes in air pressure above a liquid to be dispensed from a container mounted on a probe |
NZ215865A (en) * | 1985-04-22 | 1988-10-28 | Commw Serum Lab Commission | Method of determining the active site of a receptor-binding analogue |
FR2584498B1 (fr) * | 1985-07-02 | 1987-10-16 | Centre Nat Rech Scient | Dispositif pour detecter sur une feuille de nitrocellulose la presence de complexes macromoleculaires, tels que antigenes/anticorps et procede de mise en oeuvre. |
US5043265A (en) * | 1985-08-05 | 1991-08-27 | 501 Rijksuniversiteit Leiden | Inorganic phosphor labelled macromolecules; a process for their preparation and their use for immunological or immunocytochemical assays |
US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
ATE88761T1 (de) * | 1986-01-10 | 1993-05-15 | Amoco Corp | Kompetitiver homogener test. |
US5447841A (en) * | 1986-01-16 | 1995-09-05 | The Regents Of The Univ. Of California | Methods for chromosome-specific staining |
US4855225A (en) * | 1986-02-07 | 1989-08-08 | Applied Biosystems, Inc. | Method of detecting electrophoretically separated oligonucleotides |
US4868103A (en) * | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
US5348855A (en) * | 1986-03-05 | 1994-09-20 | Miles Inc. | Assay for nucleic acid sequences in an unpurified sample |
NO870613L (no) * | 1986-03-05 | 1987-09-07 | Molecular Diagnostics Inc | Deteksjon av mikroorganismer i en prve inneholdende nukleinsyre. |
US4925785A (en) * | 1986-03-07 | 1990-05-15 | Biotechnica Diagnostics, Inc. | Nucleic acid hybridization assays |
US4728591A (en) † | 1986-03-07 | 1988-03-01 | Trustees Of Boston University | Self-assembled nanometer lithographic masks and templates and method for parallel fabrication of nanometer scale multi-device structures |
CA1284931C (en) * | 1986-03-13 | 1991-06-18 | Henry A. Erlich | Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
US5310893A (en) * | 1986-03-31 | 1994-05-10 | Hoffmann-La Roche Inc. | Method for HLA DP typing |
JPH0833320B2 (ja) * | 1986-03-20 | 1996-03-29 | 株式会社東芝 | 自動化学分析装置 |
US4906439A (en) * | 1986-03-25 | 1990-03-06 | Pb Diagnostic Systems, Inc. | Biological diagnostic device and method of use |
US4937188A (en) * | 1986-04-15 | 1990-06-26 | Northeastern University | Enzyme activity amplification method for increasing assay sensitivity |
US4981783A (en) * | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
JPH0652227B2 (ja) * | 1986-04-25 | 1994-07-06 | 梅谷 陽二 | 微小注入量測定装置 |
US4966646A (en) * | 1986-09-24 | 1990-10-30 | Board Of Trustees Of Leland Stanford University | Method of making an integrated, microminiature electric-to-fluidic valve |
US4943032A (en) * | 1986-09-24 | 1990-07-24 | Stanford University | Integrated, microminiature electric to fluidic valve and pressure/flow regulator |
AU603617B2 (en) * | 1986-11-17 | 1990-11-22 | Abbott Laboratories | Apparatus and process for reagent fluid dispensing and printing |
US4877745A (en) * | 1986-11-17 | 1989-10-31 | Abbott Laboratories | Apparatus and process for reagent fluid dispensing and printing |
US5028525A (en) * | 1986-11-24 | 1991-07-02 | Regents Of The University Of California | Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ |
US5175209A (en) * | 1987-01-06 | 1992-12-29 | Baylor College Of Medicine | Porous wafer for segmented synthesis of biopolymers |
US4762881A (en) * | 1987-01-09 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Photoreactive benzoylphenylalanines and related peptides |
US4861866A (en) * | 1987-01-21 | 1989-08-29 | Eldex Laboratories, Inc. | Continuous flow peptide synthesizer |
US4834946A (en) * | 1987-02-05 | 1989-05-30 | Levin Andrew E | Apparatus for blot screening numerous, small volume, antibody solutions |
US5077085A (en) * | 1987-03-06 | 1991-12-31 | Schnur Joel M | High resolution metal patterning of ultra-thin films on solid substrates |
US5079600A (en) * | 1987-03-06 | 1992-01-07 | Schnur Joel M | High resolution patterning on solid substrates |
AU601021B2 (en) * | 1987-03-11 | 1990-08-30 | Molecular Diagnostics, Inc. | Assay for necleic acid sequences in a sample |
US5026773A (en) * | 1987-03-11 | 1991-06-25 | Samuel Steel | Apparatus for a solid phase synthesis of peptide analogs |
US5037882A (en) * | 1987-03-11 | 1991-08-06 | Steel Samuel L | Synthesis of oligonucleotide analogs |
JPS63223557A (ja) * | 1987-03-13 | 1988-09-19 | Nec Corp | 半導体バイオセンサの製造方法 |
US5202231A (en) * | 1987-04-01 | 1993-04-13 | Drmanac Radoje T | Method of sequencing of genomes by hybridization of oligonucleotide probes |
US5525464A (en) * | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
US4997521A (en) * | 1987-05-20 | 1991-03-05 | Massachusetts Institute Of Technology | Electrostatic micromotor |
US4874500A (en) * | 1987-07-15 | 1989-10-17 | Sri International | Microelectrochemical sensor and sensor array |
US4923901A (en) * | 1987-09-04 | 1990-05-08 | Millipore Corporation | Membranes with bound oligonucleotides and peptides |
US5011770A (en) * | 1987-09-04 | 1991-04-30 | Molecular Devices, Inc. | DNA detection method |
US5082830A (en) * | 1988-02-26 | 1992-01-21 | Enzo Biochem, Inc. | End labeled nucleotide probe |
GB8810400D0 (en) * | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
US4988617A (en) * | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
US4996646A (en) * | 1988-03-31 | 1991-02-26 | Square D Company | Microprocessor-controlled circuit breaker and system |
IL89964A0 (en) * | 1988-04-15 | 1989-12-15 | Montefiore Med Center | Method for determining malignant progression,cdna,polypeptides encoded thereby and pharmaceutical compositions containing the same |
US5002867A (en) * | 1988-04-25 | 1991-03-26 | Macevicz Stephen C | Nucleic acid sequence determination by multiple mixed oligonucleotide probes |
US5700637A (en) † | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US4978507A (en) * | 1988-05-31 | 1990-12-18 | Levin Andrew E | Fluid flow manifold for blot type screening apparatus |
AU3869289A (en) * | 1988-07-14 | 1990-02-05 | Baylor College Of Medicine | Solid phase assembly and reconstruction of biopolymers |
DK492788D0 (da) * | 1988-09-02 | 1988-09-05 | Morten Meldal | Peptidsynteseapparat |
GB8822228D0 (en) * | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5200051A (en) * | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
US5215889A (en) * | 1988-11-18 | 1993-06-01 | The Regents Of The University Of California | Catalytic and reactive polypeptides and methods for their preparation and use |
DE68925366T2 (de) * | 1988-11-18 | 1996-10-31 | Univ California | Konjugierte polypeptide und verfahren zur herstellung und verwendung |
WO1990005785A1 (en) * | 1988-11-18 | 1990-05-31 | The Regents Of The University Of California | Method for site-specifically incorporating unnatural amino acids into proteins |
US5489507A (en) * | 1988-11-30 | 1996-02-06 | Perkin-Elmer Corporation | DNA detection by color complementation |
US5077210A (en) * | 1989-01-13 | 1991-12-31 | Eigler Frances S | Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent |
US5053454A (en) * | 1989-02-15 | 1991-10-01 | Sri International | Multiple polymer synthesizer |
EP0414888A4 (en) * | 1989-03-10 | 1992-03-11 | Synaptics, Inc. | Synaptic element and array |
JPH02299598A (ja) * | 1989-04-14 | 1990-12-11 | Ro Inst For Molecular Genetics & Geneteic Res | 微視的サイズの別個の粒子と結合している核酸試料中のごく短い配列の全部または一部のオリゴヌクレチドプローブとのハイブリダイゼーションによる決定法 |
US4948565A (en) * | 1989-04-25 | 1990-08-14 | Fisher Scientific Company | Analytical system |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5279558A (en) * | 1989-06-16 | 1994-01-18 | Science Incorporated | Fluid delivery apparatus with an additive |
GB2233654A (en) | 1989-07-07 | 1991-01-16 | Nat Res Dev | Immobilised polynucleotides |
US6031074A (en) * | 1989-08-25 | 2000-02-29 | National Institutes Of Health | Automated Peptide design and synthesis |
US5110555A (en) * | 1989-09-18 | 1992-05-05 | Miles Inc. | Capillary flow apparatus for inoculation of a test substrate |
US5232829A (en) * | 1989-09-29 | 1993-08-03 | Hoffmann-La Roche Inc. | Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes |
US5023164A (en) * | 1989-10-23 | 1991-06-11 | International Business Machines Corporation | Highly sensitive dry developable deep UV photoresist |
AU6886791A (en) * | 1989-11-13 | 1991-06-13 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5215882A (en) * | 1989-11-30 | 1993-06-01 | Ortho Diagnostic Systems, Inc. | Method of immobilizing nucleic acid on a solid surface for use in nucleic acid hybridization assays |
CZ280777B6 (cs) * | 1990-02-02 | 1996-04-17 | Ústav Organické Chemie A Biochemie Avčr | Mnohonásobná automatizovaná syntéza peptidů na planárních nosičích |
US5094594A (en) * | 1990-04-23 | 1992-03-10 | Genomyx, Incorporated | Piezoelectric pumping device |
US5100626A (en) * | 1990-05-24 | 1992-03-31 | Levin Andrew E | Binding assay device with removable cassette and manifold |
KR0182619B1 (ko) * | 1990-06-15 | 1999-05-01 | 로버트 피. 블랙버언 | 내장된 분석 조립체 및 장치 |
DE4024545A1 (de) * | 1990-08-02 | 1992-02-06 | Boehringer Mannheim Gmbh | Verfahren und vorrichtung zum dosierten zufuehren einer biochemischen analysefluessigkeit auf ein target |
EP0484278B1 (de) * | 1990-11-01 | 1995-04-12 | Ciba-Geigy Ag | Vorrichtung zur Aufbereitung oder Vorbereitung von flüssigen Proben für eine chemische Analyse |
US5384262A (en) * | 1990-11-30 | 1995-01-24 | Quantix Systems, L.P. | Quantitative immunoassay for volatile organic compounds |
EP0562047A4 (en) | 1990-12-06 | 1995-11-02 | Affymax Tech Nv | Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides |
US5143849A (en) * | 1991-03-21 | 1992-09-01 | Eastman Kodak Company | Tip to surface spacing for optimum dispensing controlled by a detected pressure change in the tip |
US5846708A (en) * | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5412087A (en) * | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
EP0972564B1 (en) * | 1991-11-22 | 2003-05-28 | Affymetrix, Inc. (a Delaware Corporation) | Method of forming arrays of polymers |
US5324633A (en) * | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
ATE170293T1 (de) * | 1992-06-08 | 1998-09-15 | Behring Diagnostics Inc | Flüssigkeitsspendersystem |
US5288514A (en) * | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
WO1994008759A1 (en) * | 1992-10-16 | 1994-04-28 | Thomas Jefferson University | Method and apparatus for robotically performing sanger dideoxynucleotide dna sequencing reactions |
RU2041261C1 (ru) | 1993-08-11 | 1995-08-09 | Институт молекулярной биологии им.В.А.Энгельгардта РАН | Способ изготовления матрицы для детектирования мисматчей |
US5429807A (en) * | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
US5631734A (en) * | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
US5571639A (en) * | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5770151A (en) * | 1996-06-05 | 1998-06-23 | Molecular Dynamics, Inc. | High-speed liquid deposition device for biological molecule array formation |
-
1992
- 1992-11-20 EP EP99202441A patent/EP0972564B1/en not_active Revoked
- 1992-11-20 EP EP92925414A patent/EP0624059A4/en not_active Withdrawn
- 1992-11-20 AT AT98118908T patent/ATE293011T1/de not_active IP Right Cessation
- 1992-11-20 DE DE69233331T patent/DE69233331T3/de not_active Expired - Lifetime
- 1992-11-20 AT AT99202441T patent/ATE241426T1/de not_active IP Right Cessation
- 1992-11-20 DE DE69233501T patent/DE69233501T2/de not_active Expired - Lifetime
- 1992-11-20 US US07/980,523 patent/US5677195A/en not_active Expired - Lifetime
- 1992-11-20 EP EP98118908A patent/EP0916396B1/en not_active Expired - Lifetime
- 1992-11-20 CA CA002124087A patent/CA2124087C/en not_active Expired - Fee Related
- 1992-11-20 WO PCT/US1992/010183 patent/WO1993009668A1/en not_active Application Discontinuation
- 1992-11-20 EP EP05007868A patent/EP1588761A3/en not_active Withdrawn
- 1992-11-20 AT AT00203704T patent/ATE262374T1/de not_active IP Right Cessation
- 1992-11-20 EP EP00203704A patent/EP1086742B2/en not_active Expired - Lifetime
- 1992-11-20 JP JP50956793A patent/JP3939338B2/ja not_active Expired - Lifetime
- 1992-11-20 AU AU31481/93A patent/AU675054B2/en not_active Ceased
- 1992-11-20 DE DE69233087T patent/DE69233087T2/de not_active Expired - Lifetime
-
1995
- 1995-04-21 US US08/426,202 patent/US6136269A/en not_active Expired - Lifetime
-
1998
- 1998-08-04 US US09/129,463 patent/US6040193A/en not_active Expired - Fee Related
- 1998-12-28 HK HK00104432A patent/HK1025278A1/xx not_active IP Right Cessation
-
2002
- 2002-05-13 JP JP2002136772A patent/JP2003061657A/ja active Pending
-
2006
- 2006-02-09 JP JP2006032668A patent/JP2006194897A/ja active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000514844A (ja) * | 1996-01-23 | 2000-11-07 | ノバルティス アクチエンゲゼルシャフト | 高分子を合成する装置および方法 |
JP2011154043A (ja) * | 1996-02-09 | 2011-08-11 | Cornell Research Foundation Inc | アドレス可能アレイでのリガーゼ検出反応を用いた核酸配列の相違の検出 |
WO1999011754A1 (fr) * | 1997-08-29 | 1999-03-11 | Olympus Optical Co., Ltd. | Capillaire d'adn |
US6559296B2 (en) | 1997-08-29 | 2003-05-06 | Olympus Optical Co., Ltd. | DNA capillary |
JP2002525590A (ja) * | 1998-08-28 | 2002-08-13 | フェビット フェラリウス バイオテクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング | 分析物測定法のための支持体および該支持体を製造する方法 |
JP2003509577A (ja) * | 1999-09-20 | 2003-03-11 | ゼネラル・エレクトリック・カンパニイ | パラレル重合法 |
JP2004532382A (ja) * | 2000-09-27 | 2004-10-21 | サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シアンティフィク−シーエヌアールエス | 複数の異なるポリヌクレオチドおよび/またはペプチド配列を保有する支持体を製造するための方法および装置 |
JP2002357607A (ja) * | 2002-03-20 | 2002-12-13 | Olympus Optical Co Ltd | 集積化反応装置 |
US7359030B2 (en) | 2002-11-29 | 2008-04-15 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0916396B1 (en) | Combinatorial strategies for polymer synthesis | |
US7691330B1 (en) | Combinatorial strategies for polymer synthesis | |
US6849462B1 (en) | Combinatorial strategies for polymer synthesis | |
US5885837A (en) | Very large scale immobilized polymer synthesis using mechanically directed flow paths | |
US6121048A (en) | Method of conducting a plurality of reactions | |
US6261776B1 (en) | Nucleic acid arrays | |
US6406844B1 (en) | Very large scale immobilized polymer synthesis | |
CA2348689C (en) | Combinatorial strategies for polymer synthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050809 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20051109 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060209 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060711 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061006 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070110 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070306 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070328 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110406 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120406 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120406 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130406 Year of fee payment: 6 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130406 Year of fee payment: 6 |